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Dietary Intake and Bio-activation of Nitrite and Nitrate in Newborn Infants  
by 
Jesica Ann Jones 
Doctor of Philosophy, Graduate Program in Pharmacology 
Loma Linda University, September 2015 
Dr. Arlin B. Blood, Chairperson 
 
 Nitrate and nitrite are commonly thought of as inert end products of nitric oxide 
(NO) oxidation, possibly carcinogenic food additives, or well-water contaminants. 
However, recent studies have shown that nitrate and nitrite play an important role in 
cardiovascular and gastrointestinal homeostasis through conversion back into NO via a 
physiological system involving enterosalivary recirculation, bacterial nitrate reductases, 
and enzyme-catalyzed or acidic reduction of nitrite to NO. The diet is a key source of 
nitrate in adults; however, infants ingest significantly less nitrate due to low 
concentrations in breast milk. In the mouth, bacteria convert nitrate to nitrite, which has 
gastro-protective effects. However, these nitrate-reducing bacteria are relatively inactive 
in infants. Swallowed nitrite is reduced to NO by acid in the stomach, affecting gastric 
blood flow, mucus production, and the gastric microbiota. These effects are likely 
attenuated in the less acidic neonatal stomach. Systemically, nitrite acts as a reservoir of 
NO bioactivity that can protect against ischemic injury, yet plasma nitrite concentrations 
fall dramatically at birth and remain markedly lower than in adults for the first few weeks 
of life. The physiological importance of the diminished nitrate→nitrite→NO axis in 
infants and its implications in the etiology and treatment of newborn diseases such as 
necrotizing enterocolitis and hypoxic/ischemic injury are yet to be determined. 
 1 
CHAPTER ONE 
INTRODUCTION 
 
 This dissertation shows that nitric oxide bioavailability is markedly lower in 
newborn infants than adults. This is characterized by low dietary nitrate and nitrite 
ingestion, a lack of oral bacterial nitrate reductase activity, enhanced urinary nitrite 
excretion, and a rapid fall in plasma nitrite levels at birth. Nitric oxide (NO), a potent 
vasodilator formed by nitric oxide synthases, is rapidly oxidized to nitrite (NO2-) and 
nitrate (NO3-) in the body. Although the biological transformation of NO to nitrite and 
nitrate was previously believed to be unidirectional, recent studies have demonstrated 
pathways by which nitrate is converted to nitrite and nitrite back into NO via a nitrate → 
nitrite → NO axis (1).  
 The key steps in nitrate and nitrite transport and metabolism are shown in Figure 
1 and consist of 1) the introduction of nitrate into the mouth by the diet or active transport 
from plasma into the saliva by the salivary glands, 2) reduction of nitrate to nitrite by oral 
bacteria, 3) ingestion of nitrite, which is either converted to NO in the stomach or 
absorbed into the blood stream, 4) oxidation of nitrite and NO back into nitrate which can 
then again be secreted into the saliva, and 5) oxidation of NO into nitrite in the plasma 
and tissues (2). 
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Figure 1. Simplified schema showing the pathways and interconversions of NO, nitrite, 
and nitrate. 1.) Nitrate enters the mouth from the diet and from the plasma by a 
concentrating action of the salivary glands. 2.) In the mouth nitrate is converted to nitrite 
by commensal bacteria on the tongue (3). 3.) In the acid milieu of the stomach nitrite is 
converted to NO by disproportionation (4) or absorbed into the circulation. Nitrite may 
also be converted to NO in blood and tissues by the action of metalloproteins (2). NO, 
deriving from nitrite or from the conversion of L-arginine to L-citrulline by eNOS, can be 
converted to 4.) nitrate by reaction with oxyhemoglobin (5) or 5.) nitrite by 
ceruloplasmin (6).  
 
 Via this endothelial NO synthase (eNOS)-independent pathway, nitrate and nitrite 
are gaining recognition as potential reservoirs of NO bioactivity. This has important 
physiological implications considering NO’s wide range of actions throughout the body, 
including regulation of vascular homeostasis, neurotransmission, host defense, redox 
signaling, and cellular respiration (1). Under hypoxic and ischemic conditions in the 
circulation and tissues, nitrite is thought to act as a vasodilator via conversion to NO (7-
 3 
10). This is of particular importance in the ischemic heart, for example (11). More than 
20 studies now show that increasing circulating nitrite levels, even only two-fold higher 
than basal levels, protects against ischemic stress in the brain, heart, lungs, liver, and 
kidney (see review by Dezfulian, 2007 (12)). Clearly, nitrite shows promise as a therapy 
in a multitude of vascular pathologies. Indeed, preclinical trials are currently testing 
nitrite as a therapy for pulmonary hypertension (13) and acute myocardial infarction (14). 
Furthermore, in the gastrointestinal tract, nitrite-derived NO kills pathogenic bacteria, 
protects against gastric ulcers, and increases gastric mucus production and local intestinal 
blood flow (15-18). Given these beneficial effects in adults and animals, we asked if 
nitrite would also be protective in premature infants who are at significant risk of 
suffering from hypoxic/ischemic injury due to dysregulation of cerebral blood flow (e.g. 
intraventricular hemorrhage and periventricular leukomalacia) and episodes of inadequate 
systemic oxygenation. We reasoned that low plasma nitrite levels in preterm infants 
could potentially predispose them to the severe effects of hypoxia and ischemia. 
Specifically, we hypothesized that preterm infants would have low plasma nitrite levels 
because of diminished activity of each step of the nitrate → nitrite → NO axis. To 
address our questions, we looked at the dietary intake of nitrate and nitrite, the bacterial 
conversion of salivary nitrate to nitrite, and plasma and urine nitrite levels in preterm and 
term newborn infants.   
 
Dietary Nitrate and Nitrite 
 While about 70% of circulating nitrite comes from eNOS-derived NO oxidation 
(19), dietary intake of nitrate and nitrite also contributes to resting nitrite concentrations. 
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High levels of nitrate and nitrite are found naturally in green-leafy vegetables like 
spinach and beetroot and fruits like strawberries. They are also found in high levels in 
processed meat because they are used as curing agents (20). Consumption of dietary 
nitrate elevates plasma nitrite, as shown by Lundberg and Govoni who found that adults 
who consumed the equivalent of 300 g of spinach1 saw their plasma nitrite levels increase 
from 123 ± 19 nM to 392 ± 68 nM, a striking 4-fold increase, ninety minutes after nitrate 
ingestion (21). Two further studies highlight the importance of dietary intake by showing 
that plasma nitrite and nitrate concentrations drop by nearly 50% in rats given diets low 
in nitrite and nitrate (22-23). Accumulating evidence now indicates that dietary nitrate 
ingestion, and subsequent elevation in plasma nitrite, has significant cardiovascular 
effects. Increasing dietary nitrate, even at relatively low doses 2(24), has consistently 
been shown to decrease blood pressure in healthy normotensive people (24-26) and now 
recently in patients with chronic obstructive pulmonary disease (27) and high blood 
pressure (28). Furthermore, it protects against ischemia-reperfusion-induced endothelial 
dysfunction, decreases platelet aggregation (25), decreases the oxygen cost of exercise, 
and improves exercise tolerance (29). It is now proposed that the high nitrate content in 
vegetables is one reason why the Mediterranean and Dietary Approaches to Stop 
Hypertension (DASH) diets are thought to be so cardioprotective (20). Considering the 
important gastro- and cardioprotective effects of nitrate and nitrite ingestion in adults, we 
saw the importance of measuring the levels of nitrate and nitrite in the diet of newborn 
infants. Given the close link between plasma nitrite and nitrite/nitrate ingestion, we 
                                                 
1 The dose of nitrate used was 10 mg/ml. 
2 Administration of 100 g of beetroot juice produces a significant drop in systolic and diastolic blood 
pressures. 
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hypothesized that diminished nitrite/nitrate ingestion in premature infants would lead to 
low plasma nitrite levels. 
 The second chapter of this dissertation describes our work of measuring dietary 
nitrite and nitrate ingestion in newborn infants. To estimate the amount of nitrate and 
nitrite infants ingest daily, we measured nitrite and nitrate concentrations in breast milk, 
formula, and parenteral nutrition. In addition, we looked at how clinical practices, such as 
freezing and thawing breast milk, effect the concentrations of nitrite and nitrate.  
 
Salivary Nitrate and Nitrite 
 The third chapter of this dissertation describes our studies of the oral component 
of the nitrate → nitrite → NO axis in infants. In adults, the salivary glands concentrate 
twenty five percent of circulating nitrate into the saliva, leading to nearly ten-fold higher 
concentrations in fasting saliva (~200 µM in saliva versus ~20-40 µM in the plasma) 
(21). Twenty percent of this nitrate, together with nitrate from the diet, is reduced to 
nitrite by the normal microflora on the tongue. Although nitrate ingestion plays an 
important role in determining plasma nitrite levels, it is critically dependent on this 
bacterial reduction of salivary nitrate to nitrite. Adults who consume a high nitrate meal 
while using antibacterial mouth rinse do not have the corresponding postprandial rise in 
plasma nitrite (30). Moreover, if subjects refrain from swallowing saliva after a dietary 
nitrate load or are given antibacterial mouthwash to decrease bacterial nitrate-reducing 
activity, the hypotensive effects of nitrate are attenuated and there is no inhibition of 
platelet aggregation (25, 31). Thus, the many beneficial effects of increasing dietary 
nitrate are only seen when there is bacterial activation of nitrate to nitrite.  
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 Due to the importance of these bacteria in the nitrate → nitrite → NO axis in 
adults, we sought to measure their activity in newborn infants. Conventional wisdom is 
that the fetus is sterile3 and then acquires bacteria during birth and in the following weeks 
from the mother’s skin and breast milk and the surrounding environment (33). However, 
it was unknown when infants acquire nitrate reducing bacteria and are able to reduce 
salivary nitrate effectively. Furthermore, it was unknown if premature infants, who often 
receive broad-spectrum antibiotics that would impact bacterial growth (34), have delayed 
colonization compared to term infants. Thus, we measured the activity of the specific oral 
nitrate-reducing bacteria in both term and preterm infants, in outpatient and intensive-
care settings. We also address whether infants are able to concentrate nitrate from the 
blood into the saliva and how this impacts their salivary nitrate and nitrite concentrations 
and subsequent ingestion.  Additionally, we show how a lack of oral nitrate reducing 
bacteria influences plasma nitrite levels in adults. 
 
Plasma and Urine Nitrite 
 Plasma nitrite concentrations of healthy term newborns are measured to be 0.18 ± 
0.03 µM (35). These are ~30% lower than the concentrations of adults, which typically 
range from 50 to 300 nM (2). Given that elevated nitrite levels protect against ischemic 
injury, the reverse is also potentially true: a deficiency in nitrite would enhance risk of 
injury. Thus, a significant reduction in plasma nitrite may put newborn infants, and 
                                                 
3 Intriguing new data suggest that the fetus is not, in fact, sterile and receives bacterial colonization from 
the placenta (32). Interestingly, the microbiome of the placenta is strikingly similar to that of the mother’s 
oral flora and could potentially include these nitrate-reducing bacteria (32), although this remains to be 
determined. 
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particularly those born prematurely, at an even higher risk for diseases that involve 
ischemic injury such as necrotizing enterocolitis (NEC).  
  As the most common gastrointestinal disease among premature infants, NEC 
affects approximately 5-14% of infants born weighing less than 1500 grams (36-38). 
Despite over thirty years of clinical management, mortality rates in patients with NEC 
remain as high as 20% and the underlying cause remains largely unknown (36, 39). 
Premature birth is a prominent risk factor. Consensus is emerging that NEC results from 
epithelial mucosal injury secondary to prematurity, feeding substrate, weakened immune 
resistance to bacteria, and impaired response to stressors such as ischemia (40, 41). 
Considering nitrite’s protective effects in the gastrointestinal tract and in animal models 
of ischemia, we hypothesized that preterm infants who are diagnosed with NEC have 
lower plasma nitrite levels in the days preceding diagnosis compared to other preterm 
infants, term infants, and adults. As discussed in chapter four, we tested this hypothesis 
by collecting plasma from preterm infants at risk for NEC for the first three weeks of life. 
We also measured the nitrite concentration in urine to determine whether NEC, and any 
associated changes in plasma nitrite levels, may impact nitrite excretion in these infants.   
 In addition to measuring plasma nitrite levels in infants at risk for NEC, we also 
attempted to address whether dietary nitrite supplementation would prevent NEC in a 
newborn rat pup model of the disease. However, due challenges with this animal model, 
we were unable to adequately test our hypothesis. A more thorough explanation of these 
experiments and the challenges we encountered appears in the discussion of this 
dissertation.   
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Summary 
 The studies described herein characterize the nitrate → nitrite → NO axis in 
newborn infants. Specifically, we measured the levels of nitrate and nitrite in breast milk, 
formula, and parenteral nutrition (Chapter 2), the oral bacterial nitrate reducing activity 
(Chapter 3), and the plasma and urinary nitrite levels in preterm infants at risk for NEC 
(Chapter 4). This work reveals that newborn infants differ greatly from adults due to low 
nitrate and nitrite ingestion, negligible bacterial nitrate reduction in the oral cavity, high 
urinary nitrite excretion, and diminished plasma nitrite levels. These findings give us a 
baseline of nitrate and nitrite bioactivity in newborn infants and help us to begin to 
address the possibility of using nitrite supplementation as a therapeutic intervention 
against hypoxic and ischemic pathologies common to newborn infants.   
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CHAPTER TWO 
NITRITE AND NITRATE CONCENTRATIONS AND METABOLISM IN 
BREAST MILK, INFANT FORMULA, AND PARENTERAL NUTRITION 
 
Abstract 
 Dietary nitrate and nitrite are sources of gastric NO, which modulates blood flow, 
mucus production, and microbial flora. However, the intake and importance of these 
anions in infants is largely unknown. Nitrate and nitrite levels were measured in breast 
milk of mothers of preterm and term infants, infant formulas, and parenteral nutrition. 
Nitrite metabolism in breast milk was measured after freeze-thawing, at different 
temperatures, varying oxygen tensions, and after inhibition of potential nitrite-
metabolizing enzymes. Nitrite concentrations averaged 0.07 ± 0.01 μM in milk of 
mothers of preterm infants, less than that of term infants (0.13 ± 0.02 μM) (P < .01). 
Nitrate concentrations averaged 13.6 ± 3.7 μM and 12.7 ± 4.9 μM, respectively. Nitrite 
and nitrate concentrations in infant formulas varied from undetectable to many-fold more 
than breast milk. Concentrations in parenteral nutrition were equivalent to or lower than 
those of breast milk. Freeze-thawing decreased nitrite concentration ~64%, falling with a 
half-life of 32 minutes at 37 C. The disappearance of nitrite was oxygen-dependent and 
prevented by ferricyanide and three inhibitors of lactoperoxidase. Nitrite concentrations 
in breast milk decrease with storage and freeze-thawing, a decline likely mediated by 
lactoperoxidase. Compared to adults, infants ingest relatively little nitrite and nitrate, 
which may be of importance in the modulation of blood flow and the bacterial flora of the 
infant GI tract, especially given the protective effects of swallowed nitrite. 
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Introduction 
 Since being established as a potent vasodilator, nitric oxide (NO) has been one of 
the most intensely studied compounds in biology and is now considered to be an essential 
signaling molecule in a diverse set of pathways. Endogenous NO is produced 
predominantly through the conversion of L-arginine to L-citrulline by NO synthase 
enzymes. Through reactions with metal-containing proteins and oxygen, endogenous NO 
is rapidly oxidized to nitrite (NO2-) and nitrate (NO3-). Although these anions were once 
thought to be inert at physiological concentrations, more recent evidence indicates that 
nitrite plays a significant role in cardiovascular homeostasis (1) and protects against 
hypoxic and ischemic stress in the brain, (2,3) heart, (4,5)  lungs, (6) and kidney (7). 
Thus, there is growing interest in factors that contribute to the concentrations of nitrite in 
the body. 
 A large portion of plasma nitrite is derived from the oxidation of NO produced by 
endothelial NO synthases (8). However, plasma nitrite concentrations are also influenced 
by the ingestion of nitrite and nitrate, the latter being converted to nitrite in the mouth by 
commensal bacteria present on the dorsal surface of the tongue (9). The oral conversion 
of nitrate to nitrite is enhanced by active secretion of nitrate from the blood into the 
saliva. Once swallowed, the salivary nitrite can contribute to plasma nitrite 
concentrations, (10) or it can be protonated to nitrous acid resulting in a cascade of 
reactions leading to several bioactive products including nitrotyrosines, nitrosothiols, and 
nitrated lipids (see review by Rocha et al (11)). Although the chemistry of nitrite in the 
acidic gastric milieu is not fully characterized, it likely plays a role in the observed effects 
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of ingested nitrite in the adult rat. These include increased gastric blood flow (12,13) and 
mucus production (13) and protection against ulcers (12,14). 
 In the newborn period, breast milk and artificial breast milk substitutes (referred 
to herein as “infant formulas”) are the sole dietary sources of nitrate and nitrite. As will 
be discussed in chapter three, the nitrate-nitrite-NO pathway of adults does not similarly 
function in newborn infants due to diminished bacterial conversion of nitrate to nitrite in 
the mouth, (15) making the diet a particularly important source of nitrite. Indeed, plasma 
nitrite levels are lower in newborn infants in the neonatal intensive care unit (NICU) than 
in adults, (16) but the contribution of dietary nitrite and nitrate is not known. 
Concentrations of nitrate and nitrite in human breast milk have previously been reported 
in milk from mothers of healthy term infants (17,18). However, the effect of preterm 
birth and of common manipulations such as freeze-thaw cycles and storage on these 
concentrations have not been reported. 
 In this study we hypothesized that the freeze-thaw and storage of breast milk 
results in significant reductions in the dietary intake of nitrate and nitrite of newborns. 
We further hypothesized that nitrite and nitrate intake would be significantly reduced in 
infants receiving infant formula or intravenous parenteral nutrition (PN) compared to 
infants receiving fresh breast milk. We report that the levels of nitrate and nitrite change 
in the handling and storage of breast milk and describe potential mechanisms by which 
these levels change, including an examination of the roles of various key milk proteins 
that may contribute to nitrite metabolism. 
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Methods 
 The experimental protocols were approved by the Institutional Review Board of 
Loma Linda University. All chemicals were purchased from Sigma Aldrich (St Louis, 
MO) unless otherwise specified. 
 
Breast Milk and Formula Collection and Processing 
 Fresh breast milk was collected from 11 mothers of term infants and 13 mothers 
of preterm infants. The demographics of these mothers and their infants are provided in 
Table 1.  
 
Table 1. Demographics of breast milk study participants 
 
Characteristic 
Term 
(>36 weeks) 
Preterm 
(>35 weeks) 
Number of women, n 11 13 
Maternal age, years 28.4 ± 2.4 28.9 ± 2.0 
Parity, n 2.0 ± 0.7 3.5 ± 0.7 
Times breast pumped before donation, n 4.2 ± 0.6 3.8 ± 0.4 
Number of infants, n 11 13 
Gestational age, weeks 39.4 ± 0.3 30.8 ± 0.7 
Birth weight, grams 3158 ± 323 1390 ± 180 
Infant age at time of collection, days 24.3 ± 8.7 18.9 ± 3.9 
 
 
Feeding, breast pumping, and milk collection routines were not changed by participation 
in the study. After milk had been expressed for the first two minutes of pumping, a 3 mL 
sample of newly expressed milk was collected in a polyurethane bottle, then divided into 
500 µL aliquots and placed on ice. A portion of these aliquots was then immediately 
placed in a −20 C freezer, while the remainder was assayed for nitrite and nitrate 
concentrations within 30 minutes of collection. To measure the effect of freeze-thawing, 
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frozen samples were thawed on ice ~48 hours after collection and then assayed for nitrite 
and nitrate. 
 Nitrite concentrations of colostrum (milk expressed days 1-3), transition milk 
(expressed days 4-7), and mature milk (expressed days >7) (18) were measured to follow 
changes during the first 3 weeks after giving birth. Samples were collected daily from 12 
lactating women and immediately stored at −20 C until assay. Nitrite and nitrate 
concentrations were also analyzed in a number of infant formulas used in the NICU of 
the Loma Linda University Children’s Hospital (LLUCH). These included: Enfamil® 
Premature Lipil (Mead Johnson Nutritionals, Evansville, IN); Enfamil® Lacto Free Lipil, 
Enfamil® ProSobee® Lipil, Enfamil® EnfaCare® 22, Enfamil® Premium Infant, 
Similac® Special Care (Abbott Nutrition, Columbus, OH); Similac NeoSure®, Similac 
Advance EarlyShield®, Pregestimil® Lipil (Mead Johnson Nutritionals); and Nestlé® 
Good Start® (Nestlé Infant Nutrition, Florham Park, NJ). Assays were performed in 3 
samples from 2 different lots of each formula. The nitrite concentrations were also 
measured in 5 samples of starter parental nutrition (sPN) and 14 samples of parenteral 
nutrition (PN) used for infants unable to receive milk or formula feeds. 
 
Nitrite Metabolism in Breast Milk 
 The metabolism of nitrite in breast milk was assessed in a series of experiments in 
which nitrite was added to freeze-thawed samples of breast milk to initial concentrations 
of ~12 μM. The milk was then incubated at 37 C (unless otherwise stated) and changes in 
nitrite concentrations were measured over a 5-hour time course. 
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 To determine the effect of temperature on the metabolism of nitrite in breast milk, 
samples were incubated at 0, 10, 25, and 37 C. In a separate study, aliquots of milk were 
boiled for 5 minutes to denature proteins prior to incubation at 37 C. To test whether 
nitrite was being oxidized to nitrate, nitrite was added to 6 samples of milk and both 
nitrite and nitrate concentrations were measured over a 5-hour time course. In a separate 
experiment, additional nitrite was added to breast milk samples for final concentrations 
ranging from 10 μM to 160 μM and the increase in nitrate was measured after 5 hours. 
The increase in the nitrate concentration in a control sample of milk was subtracted from 
the rise in nitrate measured in the nitrite supplemented samples and plotted versus the 
initial nitrite concentration. 
 To assess the role of lipids in the stability of nitrite in breast milk, lipids were 
removed from 10 samples of milk by either chemical or centrifugation methods. The 
chemical method utilized an adaptation of a method for the delipidation of plasma, (19) 
while the centrifugation method involved centrifuging the milk twice at 13,400 rpm for 
90 seconds. The lipid content was measured before and after the delipidation procedures 
using a Calais Human Milk Analyzer, a midrange infrared spectrophotometer (Metron 
Instruments, Inc, Solon, OH). 
 To measure whether nitrite is reduced to NO in breast milk, nitrite was added to 
breast milk and then 100 μL of sample was immediately injected into buffered saline 
solution (pH = 7.4) in a purge vessel being continuously sparged with argon in line with a 
chemiluminescence NO detector. The presence of NO formation was detected over a 
period of 20 minutes (model 280i NO analyzer, Sievers Instruments, Boulder, CO). The 
lower limit of NO detection by this method was 20 nM. The possibility of a flux of nitrite 
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reduction to NO that could subsequently be oxidized back into nitrite was examined by 
incubating milk samples with the NO scavenger 2-4-carboxyphenyl-4,4,5,5-
tetramethylimidazoline-1-oxyl-3-oxide (cPTIO) (final concentration 200 µM). 
 Additionally, to address the possibility that nitrite was being reduced to NO and 
then combining with thiols to produce s-nitrosothiols, nitrosothiol concentrations were 
measured in 6 samples of breast milk over a 3-hour period following the addition of 
nitrite using a method described previously (20). The possible role of thiols was also 
assessed by measuring the effect of addition of 2 mM N-ethylmaleimide (NEM) (21) on 
the rate of nitrite metabolism. To assess whether nitrite metabolism was dependent on 
enzymes with oxidizable transition metals, experiments were performed after addition of 
10 mM ferricyanide (FeCN). 
 To determine the role of dissolved oxygen in nitrite metabolism in breast milk, 6 
samples of milk were equilibrated with gas phases of various mixtures of nitrogen and 
oxygen. The oxygen tension of the samples were adjusted to approximately <5, 7, 37, 73, 
or >600 mmHg by measuring the partial pressure of oxygen (PO2) in the sample 
(Radiometer, model ABL5, Copenhagen, Denmark). The rate of nitrite metabolism was 
determined by measuring the magnitude of decrease in nitrite concentrations after 
incubation for 60 minutes at 37 C. 
 To test the possibility that xanthine oxidase was involved in the metabolism of 
nitrite, experiments were conducted following the addition of 100 µM of the selective 
antagonist allopurinol. A possible role for the enzyme lactoperoxidase (LPO) was studied 
by adding 1 of 3 selective inhibitors of LPO to samples of breast milk. First, to inactivate 
the heme center of LPO, 10 µM of 2-mercaptio-1-methylimidazole (2-MMI) was added 
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to breast milk. As a second test, 4 mM 3-amino-1,2,4-triazole (3-AT), a compound that 
inhibits LPO by covalent binding to the polypeptide chain of LPO rather than the heme, 
(22) was added to a separate set of samples. In a third set of samples, the LPO inhibitor 
dapson was added to a concentration of 0.6 mmol/L. Optimal concentrations for each 
inhibitor were chosen in accordance with those used in the literature (22-25). To assess 
whether addition of exogenous LPO would accelerate the loss of nitrite, 10 µL of 1.33 
mM LPO from bovine milk was added to 5 mL of breast milk for a final LPO 
concentration of 500 nM. Nitrite was added to the sample immediately before 1 mM 
hydrogen peroxide was added to initiate the reaction. Control samples lacked hydrogen 
peroxide. The samples were incubated at 37 C and the nitrite concentrations were 
measured after 10 seconds and 1, 2, 3, 30, and 60 minutes. 
 
Nitrite and Nitrate Assays 
 Nitrite concentrations were measured by triiodide chemiluminescence as 
described by Pelletier et al, (26) enabling quantification above 10 nM with a precision of 
±5 nM. Nitrate concentrations were measured by triiodide chemiluminescence after 
reduction to nitrite with a nitrate reducing enzyme as previously described (15). 
 
Data Analysis 
 Data are presented as mean ± standard error. Differences between study groups 
were detected using a t-test when the tested hypothesis involved only two sample groups 
and a 1-way ANOVA followed by Bonferroni post hoc analysis when three or more 
sample groups were involved. One-way ANOVA with repeated measures was used to 
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detect significant changes from baseline measurements in time-course experiments. Two-
way ANOVA followed by Bonferroni post hoc analysis was used to detect significant 
differences between groups in time-course experiments. The overall rate of nitrite 
metabolism in breast milk was determined by fitting nitrite disappearance curves to a 
monoexponential equation. Where indicated, the initial rate of nitrite metabolism was 
determined as the amount of nitrite consumed during the first 60 minutes following 
addition of nitrite. Statistical analyses were performed using Prism 5 for Mac OS X 
(Graphpad Software, Inc, La Jolla, CA). 
 
Results 
Nitrite and Nitrate Concentrations in Breast Milk and Formula 
 The nitrite concentrations of fresh and freeze-thawed breast milk from mothers of 
term and preterm infants are shown in Figure 2A. Nitrite concentrations in the milk of the 
mothers of preterm infants were significantly less than in milk from the mothers of term 
infants (0.07 ± 0.01 µM vs 0.13 ± 0.02 µM, respectively, P < .01). After freeze-thawing, 
nitrite concentrations were significantly decreased in the milk of mothers of both preterm 
and term infants (0.03 ± 0.01 µM and 0.04 ± 0.01 µM, respectively, P < .05 compared to 
fresh milk). 
 Nitrate concentrations averaged about 100-fold higher than the nitrite levels in 
breast milk, as shown in Figure 2B. Nitrate in the milk of the mothers of preterm infants 
(13.6 ± 3.7 µM) did not differ significantly from nitrate concentrations in the milk from 
mothers of term infants (12.7 ± 4.9 µM). Nitrate concentrations tended to increase 
following freeze-thawing, but this change did not reach statistical significance. 
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Figure 2. Comparison of nitrite (A) and nitrate (B) concentrations in breast milk of 
mothers of term and preterm infants and after freeze-thawing. C) Nitrite concentrations 
are higher in colostrum than transition (**p<0.01) or mature milk (***p<0.001).  
 
 
 To examine changes in nitrite concentrations in milk in the days following birth, 
samples were collected from 12 lactating mothers during the first 21 days postpartum 
(Figure 2C). In the first 3 days after birth, the nitrite concentration averaged 0.12 ± 0.03 
µM. Nitrite concentrations decreased significantly over time following parturition, falling 
to 0.05 ± 0.01 µM in days four through seven (1-way ANOVA, P < .01) and 0.01 ± 0.005 
µM in days eight through twenty one (P < .001). 
 In a convenience sample of commercially available infant formulas used 
commonly in the Loma Linda University Children’s Hospital (LLUCH) NICU, nitrite 
and nitrate concentrations averaged 0.28 ± 0.1 µM and 43 ± 5.8 µM, respectively 
(Figures 3A, 3B). The nitrite concentrations were also measured in sPN and PN. Nitrite 
concentrations averaged 0.02 ± 0.008 µM in sPN and 0.08 ± 0.03 µM in PN. Nitrate 
concentrations averaged 4.6 ± 0.2 µM in sPN and 9.5 ± 0.8 µM in PN. Figures 4A, 4B 
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include the nitrite and nitrate concentrations of the PN samples alongside the mean 
concentrations in breast milk, colostrum, and formula.  
 
 
Figure 3. Nitrite concentrations (A) and nitrate (B) concentrations in a variety of 
formulas used in neonatal intensive care units. Nitrite levels vary widely, ranging from 
barely detectable to more than 13-fold higher than breast milk. 
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Figure 4. Summary nitrite (A) and nitrate (B) concentrations in all forms of nutrition 
provided to newborns in an intensive care setting. The nitrite and nitrate concentrations in 
starter PN and PN samples are similar to those found in breast milk. 
 
 
Nitrite Metabolism in Breast Milk 
 The lower concentrations in the freeze-thawed milk compared to fresh samples 
indicated a time-dependent metabolism of nitrite. This was confirmed by measuring the 
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disappearance of 12 µM nitrite added to freeze-thawed milk and incubated at 37 C. Under 
these conditions, nitrite concentrations decreased in a manner approximating first-order 
kinetics, with a rate constant of 0.020 ± 0.003 min–1 and an effective half-life of 32 
minutes. The initial rates of nitrite metabolism of breast milk incubated at the different 
temperatures are shown in Figure 5A. An Arrhenius plot of the nitrite concentrations and 
temperature, shown in Figure 5B, revealed an activation energy of 6551 cal•mol–1 and a 
Q10 of 1.5.  
 
 
 
Figure 5. A) Nitrite metabolism rates under various temperature conditions. B) Arrhenius 
plot of nitrite metabolism and temperature. C) Nitrate and nitrite concentrations in six 
samples of breast milk incubated over five hours. D) Relationship between initial nitrite 
concentration and nitrate production. 
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As shown in Figure 6, this rate of disappearance was temperature dependent, with rate 
constants of 0.010 ± 0.001 min–1, 0.007 ± 0.001 min–1, and 0.005 ± 0.002 min–1 at 21, 
10, and 0 C. When the milk was boiled for 5 minutes to denature proteins, the nitrite 
concentrations remained stable when incubated at 37 C (data not shown). 
 
 
Figure 6. Time-course of nitrite disappearance in samples of milk incubated under 
different temperatures, 37 C (▼), 21 C (Δ), 10 C (■), or left on ice (○). Nitrite decreased 
in a mono-exponential fashion with apparent half-lives of ~31, ~54, ~75 min, and ~100 
min, respectively.  
 
 To examine the possibility that nitrite was being oxidized to nitrate, we made 
measurements of nitrite and nitrate concentrations following addition of nitrite to an 
initial concentration of 12.5 µM in breast milk. We observed an increase in nitrate 
concentrations that was comparable in magnitude to the decrease in nitrite concentrations 
(Figure 5C), consistent with a pathway of oxidation of nitrite to nitrate. To confirm these 
results, additional nitrite was added to a second set of breast milk samples for final 
concentrations ranging from 10 to 160 μM. The increase in the nitrate concentration in a 
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control sample of milk was subtracted from the rise in nitrate in the nitrite supplemented 
samples and plotted vs. the initial nitrite concentration (Figure 5D). 
 We next examined a number of different possible mechanisms for the 
disappearance of nitrite including its reaction with lipids, oxidation/reduction, and 
enzymatic catalysis by key milk proteins. 
 The role of lipids was assessed by measuring nitrite metabolism before and after 
delipidation of breast milk samples from mothers of term infants. Fat content in these 
samples averaged 2.6 ± 0.1 g/dl and decreased to 1.1 ± 0.2 g/dl after delipification for 
samples that were delipified via the chemical process. The extent of delipification was 
similar for the centrifugation method, with the starting fat content averaging 3.2 ± 0.4 
g/dl and the ending amount averaging 0.8 ± 0.1 g/dl after delipification (P = .31). 
However, lipid removal, by either a combination of chemical delipification and 
centrifugation or centrifugation only, had no effect on the rate of metabolism of nitrite, as 
shown in Figure 7A, and thus the role of lipids could be discounted. 
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Figure 7. Initial rates of nitrite metabolism in breast milk after removal of lipids (A), 
treatment with the NO scavenger, 2-4-carboxyphenyl-4,4,5,5-tetramethylimidazoline-1-
oxyl-3-oxide (B), incubation with N-ethylmaleimide or ferricyanide (C), or at different 
partial pressures of oxygen (D). 
 
 We were unable to detect any free NO in breast milk following addition of nitrite, 
indicating no reduction of nitrite to NO. We also considered the possibility of a rapid flux 
of nitrite reduction to NO with subsequent oxidation of the NO back into nitrite. If so, the 
removal of NO being produced would be anticipated to speed the metabolic loss of nitrite 
by mass action. However, addition of the NO scavenger, cPTIO, did not change the rate 
of nitrite metabolism (Figure 7B). Alternatively, any NO produced might have 
immediately reacted with cysteine residues to produce nitroso compounds, including s-
nitrosothiols (SNO). However, we did not detect measurable amounts of SNO production 
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in any of the milk samples. The combination of these results speaks against a reductive 
process that might have converted nitrite to NO. 
 
 
Figure 8. Time course of nitrite disappearance in samples of milk treated with PBS (○), 
N-ethylmaleimide (NEM) [2mM] (▼), or ferricyanide (FeCN) [10mM] (□). The 
metabolic loss of nitrite was blocked by incubation with FeCN, suggesting the 
involvement of an oxidizable transition metal. 
 
 We also investigated the potential roles of catalytic proteins in the metabolism of 
nitrite. The prevention of nitrite metabolism after boiling milk is consistent with an 
enzyme-mediated metabolism of nitrite. The metabolic loss of nitrite was halted by the 
addition of 10 mM ferricyanide, suggesting the involvement of a protein containing an 
oxidizable transition metal (Figure 7C and Figure 8). Other experiments tested the 
possible binding of nitrite or its metabolic byproducts to thiol groups. Again, the rate of 
nitrite disappearance was not affected by the presence of 2 mM NEM used to block 
available thiol groups (Figure 7C and Figure 8).  
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 The role of oxygen in nitrite metabolism was tested by measuring rates of nitrite 
disappearance in breast milk samples after equilibration with various concentrations of 
oxygen. We found the initial rate of nitrite disappearance to be directly related to oxygen 
tensions (Figure 7D). These results are consistent with an oxygen-dependent oxidation of 
nitrite to nitrate. In further support of this mechanism, nitrate production was observed to 
increase in approximate proportion to the magnitude of nitrite disappearance, as shown in 
Figures 5C, 5D. 
 The blockade of xanthine oxidase, an enzyme previously reported to metabolize 
nitrite to NO in breast milk, (27) by addition of allopurinol had no effect on the rate of 
nitrite disappearance (Figure 9 and Figure 11A). 
 
 
Figure 9. Time course of nitrite in samples of milk treated with either PBS (▲) or with 
the xanthine oxidase inhibitor allopurinol (100 μM final concentration) (Δ). Xanthine 
oxidase appears not to be responsible for the nitrite metabolism measured in breast milk. 
   
 Lactoperoxidase, an enzyme previously reported to be present in breast milk, (28) 
has been shown to contribute to oxidative mechanisms in milk, (29) in addition to 
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catalyzing the oxidation of nitrite in vitro (30). Inhibition of LPO’s iodide-binding site 
with 2-mercaptio-1-methylimidazole resulted in the blockade of nitrite metabolism. 
Similarly, inhibiting the polypeptide chain of LPO with 3-AT resulted in the complete 
inactivation of enzymatic activity, corresponding with a lack of nitrite metabolism 
(Figure 10 and 11B). Treating milk samples with excess dapson, a potent inhibitor of 
LPO activity, also effectively prevented the loss of nitrite over time. The nitrite 
metabolism curves for milk treated with the LPO inhibitors are shown in Figure 10. The 
addition of exogenous LPO (final concentration, 500 nM) also accelerated the loss of 
nitrite, shortening the half-life from ~30 to ~16 min (Figure 11C). 
 
 
 
Figure 10. Time course of nitrite in five samples of milk treated with PBS (▼) or one of 
three inhibitors of lactoperoxidase activity: 2-mercaptio-1-methylimidazole (2-MMI) (□), 
3-amino-1,2,4-triazole (3-AT) (Δ), or Dapson (○). Inhibition of lactoperoxidase activity 
effectively blocked the metabolism of nitrite in breast milk. 
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Figure 11. Initial rates of nitrite metabolism in breast milk after treatment with the 
xanthine oxidase inhibitor allopurinol (A), inhibition of lactoperoxidase by 2-mercaptio-
1-methylimidazole, 3-amino-1,2,4-triazole, or Dapson (B), or addition of purified 
lactoperoxidase enzyme (C). 
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Discussion 
 These studies sought to determine whether the dietary intake of nitrite and nitrate 
is limited for term and preterm infants in the NICU compared to normal infants. We find 
that the dietary intake of nitrate and nitrite is significantly lower in infants receiving 
freeze-thawed breast milk or breast milk from mothers of preterm infants or in infants 
receiving PN. In addition, the intake of nitrate and nitrite of infants receiving infant 
formulas range from less than to more than that of infants receiving fresh breast milk, 
depending on the brand of formula. Finally, the findings of the current experiments also 
add a novel breast milk component to the nitrate-nitrite-NO system, with nitrite being 
oxidized to nitrate by LPO, as shown in Figure 12. 
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Figure 12. Simplified schema showing the nitrate-nitrite-NO axis. 
 
 
 We find widely variant concentrations of nitrite and nitrate in the diets of 
newborn infants in the NICU. The lowest levels of nitrite and nitrate measured were 
those in sPN at nearly undetectable concentrations, whereas standard PN had 
concentrations comparable to those of breast milk. Infant formulas, however, were found 
to have levels ranging from undetectable to nearly 100 times those of breast milk. This 
suggests that the manufacturers of commonly used infant formulas do not tightly control 
for nitrite and nitrate concentrations, especially as levels were found to vary significantly 
across different lots of the same formula. 
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 With regard to breast milk, our results show that nitrite intake is limited for 
preterm infants in the NICU compared to term infants. The milk of the mothers of 
preterm infants has significantly less nitrite than the milk of the mothers of term infants, a 
finding in line with studies that have shown that the breast milk of mothers of term and 
preterm infants differ with respect to a number of components (31-34). Consistent with 
reports that the composition of milk changes in the days postpartum, (18, 34) we find that 
nitrite concentrations decrease from relatively high levels in colostrum to lower levels in 
the days and weeks after birth. The physiological importance of this progression is not 
known, but it is worth noting that it is not matched in the care of newborns in the NICU 
where initial feeds may be delayed and concentrations in sPN are well below those of 
breast milk. 
 
Nitrite Metabolism in Breast Milk 
 In all samples of breast milk analyzed, nitrite concentrations fell after freeze-
thawing. Our experiments indicate that the mechanism for this fall involves the 
metabolism of nitrite by LPO. In support of this idea, we demonstrate that nitrite 
metabolism is oxygen-dependent, blocked by the presence of FeCN to oxidize the heme 
moiety of LPO, and is blocked by 3 different selective antagonists of LPO activity. We 
also demonstrate that the metabolism of nitrite in breast milk is accelerated by the 
addition of exogenous LPO. This idea is consistent with previous reports that LPO is 
known to contribute to oxidative mechanisms in milk (29) and to metabolize nitrite in 
vitro (30). 
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 In contrast to previous reports that nitrite is reduced to NO by xanthine oxidase in 
breast milk,(35) we observed no change in the rate of nitrite metabolism following 
addition of allopurinol to block xanthine oxidase activity. Likewise, addition of the NO 
scavenger cPTIO also had no effect. Finally, the rate of nitrite metabolism was observed 
to be directly proportional to oxygen concentrations, in contrast to the inverse 
relationship that would be expected from the reduction of nitrite by xanthine oxidase 
(36). 
 The observation that FeCN prevented nitrite metabolism, together with evidence 
of the involvement of oxygen, suggested the involvement of an oxidative process 
involving a heme-containing protein. Lactoperoxidase falls into this category and is 
known both to contribute to oxidative mechanisms in milk (38) and to metabolize nitrite 
in vitro (30). Our finding that each of the three LPO antagonists studied abolished nitrite 
disappearance strongly indicates a role for LPO in the metabolism of nitrite in breast 
milk. Further supporting the role of LPO in the metabolism of nitrite, we found that 
adding purified LPO enhanced the conversion of nitrite to nitrate by approximately 2-
fold. 
 
Neonatal Nitrite and Nitrate Ingestion 
 Based on the values reported in this study, we have estimated the daily intake of 
nitrate in newborns in the NICU and compared this to adults. Assuming a representative 
milk intake of 150 ml•kg–1•day–1 and based on the nitrite and nitrate concentrations 
measured in our study, infants consuming fresh breast milk would ingest 0.0007 mg•kg–
1•day–1 of nitrite and 0.12 mg•kg–1•day–1 of nitrate. This may be compared to adult 
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ingestion of nitrite of ~0.109 mg•kg–1•day–1 and ~2.65 mg•kg–1•day–1 of nitrate, based on 
an average of seven studies summarized by Pennington (39). Thus, on a per kg body 
weight basis, neonatal intake of nitrite and nitrate are only ~0.6% and ~5% of the adult, 
respectively. In addition, nitrite intake would decrease another 50%-75% if the milk is 
freeze-thawed prior to ingestion and by another 50% if the milk came from the mother of 
a preterm infant. For infants who are fed infant formula instead of breast milk, nitrite and 
nitrate intake may range from markedly lower to several-fold above that of breast milk–
fed infants, and all formulas provide less nitrite and nitrate than the average adult diet. 
The amount of nitrite and nitrate being administered to infants receiving PN is 50%-80% 
less than that ingested by term infants receiving fresh breast milk. To date, we are 
unaware of any adult studies examining the effects of chronically low intake of nitrate 
and nitrite similar to that of infants. Consequently, the physiological effects of this 
deficiency in newborns cannot be compared to similar deficiencies in adults. 
 
Relation to Plasma Nitrite Levels 
 We have recently shown that plasma levels of nitrite in infants in the NICU 
average only 35%-55% of the levels of adults (16). One potential explanation is the 
current finding that infants ingest far lower amounts of nitrite and nitrate relative to 
adults. Demonstrating this effect, two recent studies showed a nearly 50% reduction in 
plasma nitrite and nitrate concentrations in rats given diets low in nitrite and nitrate 
(40,41). However, it remains to be determined whether reduced plasma nitrite levels in 
newborn infants is beneficial or detrimental and thus optimal levels of nitrate and nitrite 
in the diet of infants are as yet unknown. 
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 It is important to consider that until recently, these anions were solely considered 
to be toxic by-products of NO metabolism because of their potential ability to form 
carcinogenic N-nitrosamines and methemoglobin (MetHb) (42). Cases of 
methemoglobinemia have contributed to the idea that nitrate and nitrite ingestion must be 
carefully regulated for infants less than three months of age. However, even the high 
nitrate and nitrite levels we measured in infant formulas are well below concentrations 
known to cause methemoglobinemia, so we can assume that there is a wide range of safe 
nitrite and nitrate concentrations in the nutritional sources of newborn infants used today. 
Moreover, infants exposed to nitrate intakes as high as 700 mg/day maintained nontoxic 
MetHb levels (43) and even when MetHb levels are artificially inflated in newborn cord 
blood, there is sufficient MetHb reductase activity such that the half-life of MetHb is only 
~3.5 hours (44). 
 
Clinical Implications 
 The current findings inform speculation on the relationship between ingested 
nitrate and nitrite and the occurrence of newborn necrotizing enterocolitis (NEC), a 
disease that is characterized by a combination of decreased gastrointestinal blood flow, 
breakdown of the mucus barrier lining the lumen of the gut, and invasion by pathogenic 
bacteria (45). Nitric oxide, which can be derived from swallowed nitrite, has been shown 
to counteract all three of these factors in adult animal models (13,14,46,47). It is clear 
that the dietary intake of nitrite and nitrate is significantly lower in infants compared to 
adults, whether an infant is receiving fresh breast milk, freeze-thawed breast milk, infant 
formula, or PN. We demonstrate in chapter three that the endogenous reduction of nitrate 
 39 
to nitrite is markedly diminished in the newborn infants due to a lack of oral nitrate-
reducing bacteria and significantly reduced saliva production (15). As a result, the impact 
of adding nitrate to the diet may be limited. Alternatively, addition of nitrite may provide 
an important source of NO to support the integrity of the gut lining by promoting enteric 
blood flow and mucus production. Although our results do not support the recent 
postulate that formula-fed infants are predisposed to NEC because of deficient nitrate or 
nitrite intake (48) since the concentrations in most formulas for preterm infants we 
measured were well above those of breast milk, given the protective effects of nitrite in 
the gastrointestinal tract, it is reasonable to propose that a deficiency of circulating nitrite 
could potentially predispose infants to NEC. We explore this hypothesis further in our 
work discussed in chapter four.  
 One possible consequence of low plasma nitrite concentrations would be a 
diminished capacity of this anion to function as a reservoir of NO bioactivity, a pathway 
thought to be important in protecting tissues against ischemic stress (2-7) (also see recent 
review by Weitzberg and Lundberg (50)). Animal studies from multiple laboratories, 
species, and disease models now support the idea that increasing plasma nitrite levels, in 
some cases by as little as 2- to 3-fold, may protect against hypoxic/ischemic stress (see 
review by Dezfulian et al (49)). Interestingly, plasma nitrite concentrations of healthy 
term newborns are ~30% lower than those of adults and increase by ~2-fold with no 
known adverse effects during administration of inhaled NO (20 ppm) to infants with 
pulmonary hypertension (16). However, there are not yet any clinical reports on the 
therapeutic effects or safety of exogenous nitrite to treat ischemia/reperfusion injury, and 
although it may have therapeutic possibilities, there are also inherent risks to consider. 
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For example, in adults, ingestion of nitrate results in a significant decrease in arterial 
blood pressure, (10) which would be undesirable in the care of most premature infants. In 
addition, MetHb production is of particular concern in neonates as they possess low 
levels of MetHb reductase activity, (44) and compared to adults, fetal hemoglobin is 
more rapidly oxidized to methemoglobin by reaction with nitrite (50). Thus, the 
possibility of methemoglobinemia cannot be ignored. 
 In summary, infants in neonatal intensive care units ingest markedly lower levels 
of nitrate and nitrite than adults on a per kg basis, possibly contributing to lower 
circulating concentrations in the plasma. The naturally occurring enzyme lactoperoxidase 
is likely a primary factor in the oxidation of nitrite to nitrate during the handling and 
storage of breast milk and is likely responsible for the ~65% fall in nitrite concentrations 
that occurs through freeze-thawing, potentially exacerbating the effects of the little 
dietary nitrite made available to infants. Whether this limited ingestion puts the newborn 
infant population at risk for gastrointestinal and cardiovascular diseases or whether 
supplementation of these anions in the diet would be beneficial on one hand or safe on 
the other calls for future study.  
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CHAPTER THREE 
NITRATE REDUCTASE ACTIVITY OF BACTERIA IN SALIVA OF TERM 
AND PRETERM INFANTS 
 
Abstract 
 The salivary glands of adults concentrate nitrate from plasma into saliva where it 
is converted to nitrite by bacterial nitrate reductases. Nitrite can play a beneficial role in 
adult gastrointestinal and cardiovascular physiology. When nitrite is swallowed, some of 
it is converted to NO in the stomach and may then exert protective effects in the 
gastrointestinal tract and throughout the body. It has yet to be determined either when 
newborn infants acquire oral nitrate reducing bacteria or what the effects of antimicrobial 
therapy or premature birth may be on the bacterial processing of nitrate to nitrite. We 
measured nitrate and nitrite levels in the saliva of adults and both preterm and term 
human infants in the early weeks of life. We also measured oral bacterial reductase 
activity in the saliva of both infants and adults, and characterized the species of nitrate 
reducing bacteria present. Oral bacterial conversion of nitrate to nitrite in infants was 
either undetectable or markedly lower than the conversion rates of adults. No measurable 
reductase activity was found in infants within the first two weeks of life, despite the 
presence of oral nitrate reducing bacteria such as Actinomyces odontolyticus, Veillonella 
atypica, and Rothia mucilaginosa. We conclude that relatively little nitrite reaches the 
infant gastrointestinal tract due to the lack of oral bacterial nitrate reductase activity. 
Given the importance of the nitrate–nitrite–NO axis in adults, the lack of oral nitrate-
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reducing bacteria in infants may be relevant to the vulnerability of newborns to hypoxic 
stress and gastrointestinal tract pathologies. 
 
Introduction 
 Until recently nitrite and nitrate were thought to be biologically inert at 
physiological concentrations. However, evidence now indicates that these anions play a 
significant role in cardiovascular homeostasis, and in responses to hypoxic and ischemic 
stress (See review by Lundberg et al. (1)). Nitrite has been found to provide protective 
effects in various animal models of ischemia–reperfusion (2–5). Clinical trials are 
currently evaluating the safety and efficacy of nitrite in pulmonary hypertension and 
myocardial infarction. While the mechanism underlying the protective effects of nitrite is 
not yet well understood, a common hypothesis posits that nitrite is reduced to NO, a 
reaction that can either occur spontaneously under acidic conditions such as those found 
in the stomach (6), or which may be catalyzed by a number of metal-containing proteins 
(7). Irrespective of the mechanism, there is growing consensus that nitrite is 
cytoprotective during ischemia–reperfusion insult which has lead to an interest in the 
factors that determine plasma nitrite concentrations.  
 Nitrate, which is inert in mammalian tissues, is converted to nitrite by bacteria 
normally found on the dorsal surface of the adult tongue (1, 8). These microbes act upon 
nitrate that is concentrated in the saliva by the salivary glands or ingested in the diet. 
Dietary nitrate primarily derives from vegetables (9) and from breast milk and formula, 
albeit in significantly lower levels, in the diet of newborns (10). These microbes also act 
on nitrate that is actively transported from plasma into the saliva by the salivary glands 
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(9). The resulting salivary nitrite is swallowed, and can then be converted to NO by 
nonenzymatic disproportionation in the acidic environment of the stomach (11, 12). It can 
also enter the circulation where it may serve as a long-term reservoir of NO-bioactivity 
(1). Increasing dietary nitrate lowers blood pressure (13, 14), improves exercise 
performance (1, 15, 16), and increases plasma nitrite concentrations (14, 17). Disruption 
of the salivary nitrate–nitrite–NO pathway in adults by not swallowing saliva prevents the 
fall in blood pressure associated with ingestion of nitrate (13). Thus, there is strong 
evidence that nitrate-reducing oral bacteria play an important role in determining plasma 
nitrite concentrations and the cardiovascular homeostasis of adults.  
 The bacterial colonization of the mouth and gastrointestinal tract of newborn 
infants begins at birth and progresses over the first few weeks of life (18). This 
progression is almost certainly altered in an intensive care setting where sanitary 
practices and the use of antibiotics may diminish oral bacterial quantity and nitrate 
reducing capacity. The appearance of nitrate-reducing bacteria in the mouths of newborn 
infants, whether in outpatient or intensive care settings, had not yet been characterized.  
 Our previous work has shown that plasma nitrite concentrations are lower in 
newborn infants in the neonatal intensive care unit compared to adults (19). We postulate 
that this is in part due to low oral nitrate reductase activity in newborn infants. The 
current studies were designed to measure the activity of nitrate reducing bacteria in 
saliva, to characterize the type of oral nitrate reducing bacteria in the mouth of newborn 
infants, and to compare newborn and adult salivary nitrite and nitrate concentrations. We 
also tested the hypothesis that elimination of oral nitrate-reducing bacteria leads to 
decreases in circulating nitrite in adults. Given the importance of the nitrate–nitrite–NO 
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axis in adults, the appearance and activity of oral nitrate-reducing bacteria in infants may 
contribute to reduced plasma nitrite levels and may be a significant factor in the course of 
development. 
 
Methods 
 All experimental protocols were approved by the Institutional Review Board of 
Loma Linda University. Newborn study subjects were recruited from the neonatal 
intensive care unit, well-baby nursery, and pediatric outpatient clinic of Loma Linda 
University Children’s Hospital. Infants were considered to be term if born after 36 weeks 
gestation, and to be preterm if born before 35 weeks gestation; they were excluded from 
the study if they were born at 35 or 36 weeks gestation. In addition, infants with 
congenital malformations were excluded from the study. The infants’ gestational age, 
birth weight, type of feeding, and antibiotic therapy were recorded. Adult subjects were 
healthy males and females who, ranged from 24 to 72 years of age, had not used 
antiseptic mouthwash within 24 hours, and had not received antibiotic treatment within 
two weeks prior to the study. Separate cohorts of adults were studied for the salivary 
nitrate and nitrite concentrations and nitrate reductase activity portions of the study.  
 
Salivary Nitrite and Nitrate Concentrations 
 To determine baseline salivary nitrite and nitrate concentrations, samples were 
collected from infants and adults by gently rotating a sterile cotton swab (Kendall Q-Tips, 
Tyco Healthcare Group, Mansfield, MA) against the sublingual posterior aspect of the 
tongue for 90 seconds. Samples were collected at least one hour following meals. The 
cotton end of the swab was removed and immediately transferred to 500 µL of water. The 
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weight of the cotton swab was recorded to the nearest milligram before and after 
placement in the mouth to determine the amount of saliva collected. The amount of nitrite 
and nitrate collected in the swab was determined by comparison with standard curves 
generated from known nitrite or nitrate concentrations in 200 µL of water soaked into 
swabs and prepared on each day samples were assayed. Both nitrite and nitrate standards 
resulted in a linear relationship between the nominal and measured concentrations (nitrite 
R2 = 0.98, nitrate R2 = 0.87). Nitrite levels were consistently found to be below the lower 
limit of assay detection (10 nM) in samples of dry swabs, demonstrating no background 
contamination. There was measurable background contamination of nitrate (60.32 ± 
11.61 µM) in the dry swabs, which was subtracted from the raw nitrate levels by the use 
of the standard curve. 
 
Salivary Nitrate Reductase Activity 
 Salivary samples were collected by rotating a sterile cotton swab in a single 360-
degree twisting motion against the dorsum of the tongue. The volume of saliva collected 
was determined via the weight gain of the swab. The swab tip was immediately 
transferred to 3.0 ml of sterile anaerobic BHI broth (BD bacto™ brain heart infusion; BD 
Bacto™ yeast extract, Becton Dickinson, Franklin Lakes, New Jersey; L-cysteine 
hydrochloride monohydrate, Fisher Scientific, Pittsburg PA; Hemin; Menadione; Sigma, 
St. Louis MO) and then placed in a water bath held at 37 C. Within ten minutes of 
placing the swab in broth, a baseline nitrite measurement was recorded and then 10 mM 
nitrate was added (final concentration 333 µM) to provide substrate for the bacterial 
conversion to nitrite. Nitrite concentrations were then measured at five-minute intervals 
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beginning after the first collection at one minute, and continuing for 30 min. The nitrate 
reductase activity was calculated from the slope of a linear regression fit to the plot of 
increasing nitrite concentrations over time, with the result providing nanomoles of nitrite 
production per minute per milligram of saliva collected. We verified this method of 
measuring oral nitrate reductase activity by treating four adult subjects with six antiseptic 
mouth rinse treatments consisting of 0.12% chlorhexidine solution (Peridex, 3 M ESPE 
Dental, St. Paul, MN) over a period of three days (12-hour intervals). Baseline activities 
were recorded before the mouth rinse treatment, and immediately following the last 
mouth rinse treatment, demonstrating that the subjects no longer had any measurable 
activity (Figure 13). Subsequent measurements at 8, 24, and 48 h after the last treatment 
indicated a return to baseline levels of nitrate reductase activity within 48 h. 
 
 
Figure 13. Effect of antiseptic mouthwash on the assay for oral nitrate-reducing bacteria. 
Following six treatments with antimicrobial mouth rinse at twelve hour intervals, oral 
nitrate reductase activity in four adult subjects was decreased to unmeasurable levels 
compared to baseline values. Nitrate reductase activity returned to normal within 48 h 
following the last antimicrobial mouth rinse treatment. 
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 To verify that nitrate was being metabolized in the broth as nitrite concentrations 
were increasing, we also measured the rate of nitrate disappearance using swab samples 
from five adult subjects. Over the course of the 30-min experiment, the mean rate of 
nitrate disappearance was 103 ± 20 nmol•min-1•mg-1 of saliva, while the mean rate of 
nitrite production was 47 ± 17 nmol•min-1•mg-1 (Figure 14).  
 
 
Figure 14. A) Time course of nitrite production and nitrate reduction by nitrate-reducing 
bacteria cultured from saliva samples of five adults. B) Summary of kinetic results based 
on average rates of change of nitrite and nitrate concentrations with time.  
 
 
Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite and Nitrate 
Concentrations in Adults 
 Twenty-four normal healthy adults received six mouth rinse treatments over a 
period of three days (at 12-h intervals) with either 0.12% chlorhexidine solution (n = 12) 
or saline solution (n = 12) as placebo control. Saliva and venous blood samples were 
collected just prior to the first mouth rinse, and then again one to two hours following the 
final mouth rinse. Blood was immediately added to a nitrite preservation solution (4:1 
v/v) (20), deproteinized by methanol precipitation (1:1 v/v), and stored at 70 C until 
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assay. Approximately 5 ml of saliva was collected by expectoration of passively secreted 
saliva into a 50 ml tube, which was immediately frozen until assay at a later date. 
Subjects were asked to refrain from eating high-nitrate foods (e.g. beets, radishes, 
hotdogs, and leafy greens) from 24 h prior to the first sample until after the collection of 
the final sample. 
 
Salivary Bacterial Analyses 
 To assess for the presence of bacteria capable of nitrate reductase activity, PCR 
analysis and real-time PCR was performed on bacterial DNA isolated from saliva 
collected from healthy infants in the pediatric outpatient clinic, and from preterm infants 
in the NICU and from healthy adults after six chlorhexidine treatments. We chose to test 
for the presence of the four most prevalent nitrate reducing bacterial species in the adult 
mouth (21): Veillonella atypica, Actinomyces odontolyticus, Rothia mucilaginosa, and 
Staphylococcus epidermidis. Saliva was collected using a Vacutainer™ anaerobic 
specimen collection vial (Becton–Dickinson, Sparks, Maryland) by rotating a sterile 
anaerobic specimen collector swab in one 360-degree rotation against the dorsum of the 
tongue. Swabs were stored in an anaerobic specimen collector for up to 48 h at room 
temperature after which they were placed in 5.0 ml of sterile anaerobic brain heart 
infusion (BHI) broth. The swabs were then incubated overnight at 37 C in an anaerobic 
chamber (0% O2, 99.8% N2, 0.2% H2), until the broth had reached an optical density of 
0.8–1.0 (600 nm). Bacterial DNA was extracted using a Wizard Genomic DNA 
purification kit (Promega Corporation, Madison, WI) following the manufacture’s 
protocol for isolating genomic DNA from gram positive bacteria. For efficient lysis, 60 
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µL of 10 mg/ml lysozyme and 60 µL of 10 mg/ml lysostaphin (Sigma–Aldrich, St. Louis, 
MO) were added to each sample. The DNA was resuspended in 100 µL of rehydration 
solution, quantified using a NanoDrop 2000 (Thermo Scientific, Wilmington, DE) and 
then stored at 70 C. 
 
PCR Analysis 
 Qualitative PCR was performed on the DNA samples initially to confirm the 
accuracy of the primers used for the four bacterial species of interest, and to confirm the 
presence of target bacterial genes in the DNA samples. The primers for PCR analysis are 
listed in Table 1 and were designed using the NCBI primer select program. The reaction 
mixture (50 µL) contained 1 µg of template DNA in the high fidelity PCR master mix 
(Invitrogen, Carlsbad, CA). PCR cycling conditions were 1 cycle of 5 min at 94 C 
followed by 30 cycles of 30 s at 94 C, 30 s at 54 C and 1 min at 68 C with final extension 
of 5 min at 68 C. 
 
Real-time PCR analysis 
 Real time PCR was carried out on 1 µg aliquots of purified DNA using a Smart 
cycler II (Cepheid, Sunnyvale CA). The primers for the real time analysis are listed in 
Table 2. The amplification efficiency of each primer set was determined empirically by 
using DNA template dilutions over four orders of magnitude. The amplification 
efficiency for each primer set varied between 95.1% and 102.5%, showing that the 
amplicons were generated with comparable efficiency. The specificity of the 
amplification was ascertained based on the melting peak generated during each run. 
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Table 2. Primer sequences used for bacterial PCR analysis. 
Bacterial species Target gene primer set 
  1. Veillonella atypica Forward primer- 5’ – 
GTGCTGCAGAGAGTTTGATCCTGGCTCAG -3’ 
Reverse primer-5’- 
CACGGATCCTACGGGTACCTTGTTACGACTT -3’ 
  2. Rothia mucilaginosa Forward primer-5’-AGCCTCAGGG 
ATTGATGGGTTCTT-3’ 
Reverse primer- 5’-TTCTGGTGGTT 
GTACAGGGCGTTA-3’ 
  3. Actinomyces   
      odontolyticus 
Forward primer- 5’- GCGGATTAATT 
CGATGCAACGCGA-3’ 
Reverse primer- 5’ CATTGTAGCAT 
GCGTGAAGCCCAA-3’ 
  4. Staphylococcus  
     epidermidis 
Forward primer- 5’-CTGCCTTTCAA 
TGCGAGTTGGCTT-3’ 
Reverse primer-5’-ACAGCTAAACT 
TGCAGCATGTGGG-3’ 
 
 
The real time-PCR reaction contained 12.5 µL of QuantiTect SYBR Green qPCR master 
mix (Qiagen, Valencia, CA), 0.2 µM of each gene-specific primer and 1 µL of DNA 
template. The cycling conditions were 50 C for 2 min, 95 C for 2 min, then 40 cycles of 
94 C for 15 s, 58 C for 30 s, and 72 C for 30 s. Distilled water was used as a negative 
control in each run. All reactions were carried out in triplicate. A standard curve was 
generated using dilution of the DNA from each species of bacteria plotted against the 
cycle threshold value (Ct). The concentration of DNA was converted to copy number 
using the formula n = NA – m/MW – L where n = the number of target sequence copies 
per microliter, NA = Avagadro’s constant (mol-1), m = mass of the amplicon per 
microliter, MW = mean molecular weight of 1 base pair, and L = amplicon length in base 
pairs. The Ct values obtained were plotted against DNA concentration to generate 
standard curves from which the cutoff Ct for each bacterial species was determined. The 
cutoff Ct value, above which the absence of the bacteria is indicated, was 43 for 
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Veillonella  atypica, 49 for Rothia mucilaginosa, 39 for Actinomyces odontolyticus, and 
47 for Staphylococcus epidermidis. 
 
Nitrite and Nitrate Assays 
 Nitrite concentrations were measured by triiodide chemiluminescence as 
described by Pelletier et al. (20), enabling quantification above 10 nM with a precision of 
±5 nM. Nitrate concentrations were measured by incubation of 205 µL of sample with 5 
µL nitrate reductase enzyme (10 U/ml solvent, Roche, Indianapolis IN) in 10 µL of 1 M 
HEPES (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) buffer solution (Fisher 
Scientific, Pittsburgh PA), 10 µL of 0.1 mM flavin adenine dinucleotide disodium salt 
hydrate (Sigma Aldrich, St. Louis, MO), and 20 µL of 1 mM nicotinamide adenine 
dinucleotide phosphate-oxidase tetrasodium salt (Roche, Indianapolis, IN) at 37 C for 45 
min to convert all the nitrate to nitrite, which was then measured by triiodide 
chemiluminescence. Whole blood nitrate concentrations were measured by 
chemiluminescence assay following reduction of nitrate to NO in a purge vessel 
containing vanadium III and HCl at 90 C. 
 
Data Analysis 
 Data are presented as means ± standard error. Differences between study groups 
were detected using Student’s t-test for two group comparisons and one-way ANOVA 
followed by Bonferroni post hoc analysis for comparison of three or more datasets. 
Oneway ANOVA with repeated measures was also used to detect significant changes 
from baseline measurements in time-course experiments. Two-way ANOVA followed by 
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Bonferroni post hoc analysis was used to detect significant differences between groups in 
time-course experiments. Statistical analysis was performed using Prism 5 for Mac OS X 
(Graphpad Software, Inc, La Jolla, CA). 
 
Results 
Nitrite and Nitrate Concentrations in Saliva 
 Nitrite and nitrate concentrations were measured in saliva collected from ten 
infants and twelve healthy adults. The results are shown in Figure 15 and participant 
demographics are provided in Table 3.  
 
Table 3. Saliva study infant participant demographics. 
 Infants 
Participants, n 10 
Gestational age, weeks 39 ± 0.3 
Birth weight, grams 3662 ± 170 
Age at time of collection, days 3.1 ± 0.3 
Infants receiving antibiotics, n 0 
Breast fed, n 7 
Formula and breast milk fed, n 3 
 
 
Nitrite concentrations in infant saliva averaged 8.2 ± 5.6 µM. These concentrations were 
significantly lower than adult salivary nitrite concentrations which averaged 50 ± 13 µM 
(p = 0.0501) (Figure 15A). Nitrate concentrations were measured in saliva collected from 
ten infants and fourteen adults and averaged 284 ± 83 µM in the saliva of infants and 
were not measurably different than those found in adults (681 ± 184, p = 0.11) (Figure 
15B). The newborn salivary nitrate concentrations were approximately ten-fold greater 
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than previously reported newborn plasma nitrate levels (19,22,23), demonstrating that 
salivary glands are able to concentrate nitrate from the plasma into the saliva of infants, 
and to levels comparable to adults. Notably, the amount of saliva obtained during the 
timed 90-second collection periods from infants (39 ± 8 µL) was less than the amount 
collected from adults (143 ± 15 µL) (p < 0.001). 
 
 
Figure 15. Nitrite and nitrate concentrations in saliva of infants and adults. (A) Nitrite 
concentrations in the saliva of infants (8 ± 5 µM) were less than adult saliva (55 ± 22 µM, 
*= p < 0.01). (B) Salivary nitrate levels were not significantly lower in the saliva of 
infants (328 ± 97 µM) than in the saliva of adults (538 ± 125 µM). 
 
 
 
Conversion of Nitrate to Nitrite in Saliva 
 Oral bacterial nitrate-reducing activity was measured in fresh oral swabs 
immediately after placing them in culture media. Swabs were obtained from 25 infants 
less than five days of age, from 19 infants between 14 and 40 days of age, from 9 infants 
approximately two months old, and from 13 healthy adults. The demographics of the 
infant subjects are shown in Table 4.  
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Table 4. Saliva nitrate reductase study infant participant demographics. 
 
 
NICU 
preterm 
on 
antibiotics 
NICU 
term on 
antibiotics 
NICU 
preterm 
Outpatient 
term 
NICU 
term >2 
weeks old 
NICU 
preterm > 
2 weeks 
old 
Outpatient 
> 2 weeks 
old 
Outpatient 
2 months 
Participants, n 7 6 5 7 5 8 6 9 
Gestational age, 
weeks 
32.1 ±  0.7 38.6  ±  
0.5 
32.6  ±  
0.7 
39.2  ±  
0.5 
38.4  ±  
0.5 
30.8  ±  
1.1 
38.9  ±  
0.7 
39.5  ±  
0.3 
Birth weight, grams 1495  ± 
201 
3322 ±   
86 
1964  ±  
124 
3391 ±   
140 
3350  ±  
235 
1581  ±  
174 
3199  ±  
133 
3425  ±  
127 
Age at time of 
collection, days 
3  ±  0.4 4.2  ±  0.3 4.6  ±  0.2 3.7  ±  0.4 26.6  ±  
5.6 
27.3  ±  
2.9 
17.2  ±  
1.7 
64.6  ±  
1.1 
Breast fed, n 0 2 0 3 1 0 6 7 
Nipple/gavage breast 
milk fed, n 
3 3 2 2 1 7 0 0 
Formula fed only, n 0 0 2 2 3 1 0 2 
Intravenous feeding, 
n 
4 1 1 0 0 0 0 0 
 
 
Swabs collected from infants contained similar amounts of saliva as those collected from 
adults (17 ± 1 vs. 17 ± 3 mg, respectively, p = 0.9). The rate of nitrite production in the 
cultures, normalized to the weight of the saliva collected, was linear during the 30 min 
sampling period, as shown in Figure 16A, with the slope thus providing an index of 
bacterial nitrate reductase activity. In samples taken from adults nitrite was produced at a 
rate of 147 ± 36 nmoles•min-1•mg-1. In marked contrast, however, saliva cultures from 
newborns showed little or no detectable nitrite production. 
 In the cultures collected from preterm (n = 6) and term (n = 6) infants on 
antibiotics, the rates of nitrite production were not significantly different than zero (0.05 
± 0.04 nmoles•min-1•mg-1 saliva and 0.04 ± 0.11 nmoles•min-1•mg-1 saliva, 
respectively). In addition, there was no appreciable nitrite production in the salivary 
cultures taken from preterm infants in the NICU not receiving antibiotics, or from healthy 
term infants less than two weeks of age in the well-baby nursery and outpatient clinic (4 
± 4 nmoles•min-1•mg-1 saliva and 5 ± 3 nmoles•min-1•mg-1 saliva, respectively). Nitrite 
production was detectable in saliva samples collected from healthy infants between 14 
 59 
and 40 days of age in the outpatient clinic (22 ± 15 nmoles•min-1•mg-1) as well as term 
(23 ± 12 nmoles•min-1•mg-1) and preterm infants in the NICU (28 ± 19 nmoles•min-
1•mg-1), although this activity was still measurably less than that of the adults (p < 0.01). 
Even by two months of age, the rate of nitrite production (23 ± 12 nmoles•min-1•mg-1) 
was significantly lower than that of adults (p < 0.01, Figure 16B).  
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Figure 16. A) Time course of nitrite production by nitrate-reducing bacteria cultured 
from saliva samples. After introduction of nitrate substrate into cultures, nitrite was 
measured in samples from adults (♦), infants greater than two weeks of age (◊), newborn 
infants less than five days old (○), and newborn infants less than five days old receiving 
antibiotics (▲).  B) Summary of kinetic results based on average rates of change of 
nitrite concentration with time, as shown in A. There was no significant nitrite production 
in the saliva of infants <5 days old, regardless of whether they were on antibiotics (abx). 
There was significant nitrite production in the infants older than two weeks (+ = p<0.01), 
and nitrite production was significantly greater in the adult saliva compared to infants 
(*** = p<0.001). 
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PCR Detection of Nitrate Reducing Bacteria 
 To investigate the possibility that the lack of nitrate reducing activity in the 
samples collected from infants was due to the absence of nitrate-reducing bacteria, PCR 
detection was performed on samples collected from five healthy term infants in the 
outpatient clinic and seven preterm infants in the NICU, who were all less than five days 
of age. The specificity of the amplification of target genes was confirmed by 
conventional PCR analysis (data not shown). The quantitative PCR demonstrated the 
presence of Veillonella atypica and Rothia mucilaginosa in all the infants studied. 
Actinomyces odontolyticus was present in four of the five term infants and five of the 
seven preterm infants, and Staphylococcus epidermidis was present in two of the five 
term infants and all of the preterm infants studied (Figure 17). These values suggest that 
the most abundant oral nitrate reducing bacteria in adults are also present in the mouths 
of neonates within a few days after birth. Thus, the lack of nitrate reductase activity in 
infants is more likely to be due to low abundance or activity of these bacteria as opposed 
to lack of inoculation. To assess this possibility further, PCR was also performed on eight 
adult subjects after six treatments with chlorhexidine, which lowers oral nitrate reductase 
activity by our assay to levels comparable to those of infants (see above). We found 
detectable presence of all four bacterial species in all adults studied, with the exception of 
one adult in whom Actinomyces odontolyticus was not detectable, suggesting that 
although chlorhexidine significantly decreases overall oral nitrate reducing activity, it 
does not completely eliminate the presence of nitrate reducing bacteria.  
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Figure 17. Real time PCR detection of nitrate-reducing bacteria. The presence of  
Veillonella atypica, Rothia mucilaginosa, Actinomyces odontolyticus, and Staphylococcus 
epidermidis in bacterial cultures collected from the mouths of term (●) and preterm (○) 
infants and adults () was confirmed using primers specific to the respective bacteria. 
Horizontal gray bars represent the cutoff Ct value, below which the presence of the 
bacteria is confirmed. The data indicate the presence of most of these nitrate reducing 
bacteria in the infant mouth within the first few days of life. 
 
 
Effect of Antimicrobial Mouth Rinse on Blood and Saliva Nitrite and Nitrate 
Concentrations in Adults 
 Changes in blood nitrite were examined in 24 adult subjects after three days of 
treatment with either anti-microbial mouth rinse or placebo. Mean blood nitrite 
concentration decreased by approximately 20% from 0.27 ± 0.01 µM to 0.22 ± 0.01 µM 
following chlorhexidine treatment (p < 0.05), but was not affected by the placebo. As 
shown in Figure 18, blood nitrite concentrations decreased in 9 out of 12 subjects 
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following chlorhexidine mouth rinse treatments, compared to only 5 out of 12 subjects 
with placebo mouth rinses. There were no significant differences in the blood nitrate 
concentrations of the study subjects before or after treatment with chlorhexidine (41 ± 8 
vs. 48 ± 7 µM) or placebo (35 ± 4 vs. 32 ± 6 µM, data not shown). Saliva nitrite 
concentrations fell from 322 ± 70 to 109 ± 35 µM (p < 0.01) following three days of 
antimicrobial mouthwash, and were unchanged (246 ± 54 vs. 284 ± 45 µM) following 
treatment with placebo. Saliva nitrate concentrations increased from 189 ± 39 to 1083 ± 
268 µM (p < 0.01) following the antimicrobial mouthwash, and were again unchanged 
(118 ± 40 vs. 141 ± 37 µM) following treatment with placebo. 
 
 
Figure 18. Effect of antiseptic mouth rinse on adult blood nitrite concentrations. Blood 
nitrite concentrations in healthy adult volunteers were significantly decreased by ~19% 
compared to baseline levels following six treatments with antiseptic mouth rinse 
(chlorhexidine) at 12-hour intervals (*=p<0.04). No significant change was observed in a 
parallel group of placebo (saline) control subjects. 
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Discussion 
 The current studies demonstrate that bacterial nitrate reductase activity in the 
mouth of neonates is minimal compared to that of adults. The low nitrate-reducing 
activity in the newborn persists for at least the first two months of life, and results in 
significantly lower salivary nitrite concentrations. In spite of this reduced activity, PCR 
evidence shows that newborn mouths do contain the major nitrate-reducing bacteria 
found in adults. This suggests that the diminished nitrate-reducing activity of newborns 
may be due to lower numbers of these bacteria, as opposed to a lack of inoculation. Thus, 
this study shows that oral nitrite production, which plays a prominent role in 
cardiovascular and gastrointestinal homeostasis of adults, has less capacity to function in 
neonates during the first few weeks of life.  
 
Impact of Oral Bacteria on Nitrite Ingestion 
 Normally, adults swallow on average 600 ml of saliva per day (24). To our 
knowledge, the quantification of saliva production or ingestion in newborns has not yet 
been accomplished due to obvious technical challenges. However, the newborn mouth is 
relatively dry compared to the adult mouth, as is reflected by significantly lower volumes 
of saliva collected by the oral swabs in the current study. In adults, even when nitrate-
reducing bacteria are present, not swallowing saliva effectively blocks the physiological 
effects of dietary nitrate (13). Thus, it is reasonable to hypothesize that the relatively low 
rate of saliva production in newborns, coupled with a low concentrations of nitrite in the 
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saliva and diet, has a compounded impact upon overall nitrite ingestion by newborn 
infants resulting in significantly decreased nitrite intake compared to adults. 
Linkage between Oral Bacterial Activity and Plasma Nitrite 
 We have recently observed that the blood nitrite concentration of newborn infants 
(1.4 ± 0.5 days of age) is approximately 35–55% lower than that of adults (19). The 
current studies found that a blockade of oral bacterial nitrate reduction activity in adults 
resulted in a 20% reduction in blood nitrite concentrations, demonstrating that oral nitrate 
reductase activity makes a significant contribution to basal plasma nitrite concentrations. 
This finding is consistent with experiments in which increases in plasma nitrite, 
following nitrate ingestion, have been shown to require the activity of oral bacteria (13, 
25). Notably, plasma nitrite concentrations are also heavily influenced by NO derived 
from endothelial nitric oxide synthase (eNOS) activity (26, 27). However, the rate of 
eNOS activity in newborns, relative to adults, has not been determined.  
 
Oral Bacteria 
 A number of specific nitrate-reducing bacteria, most of them facultative 
anaerobes, have been identified in the oral cavity of adult humans (21, 28). Previous 
studies have reported the presence of Veillonella and Actinomyces spp. (29, 30) in infants. 
To our knowledge, however, our work is the first to report both the presence of nitrate 
reducing bacteria and measurement of oral nitrate reducing activity. The significantly 
lower nitrate reductase activity in newborns, despite evidence of their mouths having 
been colonized by these bacteria, may be due to relatively low bacterial abundance at this 
age, a factor not measured in the current study. This idea is supported by our observation 
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of the presence of these bacteria in the mouths of adults following chlorhexidine 
treatment, concomitant with a lack of measurable nitrate reductase activity. The 
significantly lower bacterial nitrate reductase activity observed in infants in both an 
intensive care setting and the home environment, regardless of whether the infants were 
receiving antibiotics, serves as further evidence that the low nitrate reducing activity of 
newborns was not due to a delayed inoculation of these infants with nitrate-reducing 
bacteria.  
 
Study Limitations 
 We observed that salivary nitrite concentrations in adult saliva collected with 
cotton swabs (55 ± 22 µM) were consistently lower than concentrations measured in 
saliva collected by expectoration (284 ± 63 µM) in addition to being lower than most 
previously reported salivary nitrite concentrations which range from 90 to >670 µM. 
Standard curves generated by dipping swabs in small amounts of water with varying 
concentrations of nitrite were highly linear with significant slope. However, we observed 
that nitrite concentrations measured in ten expectorated adult saliva samples were 
significantly higher than concentrations measured from samples collected at the same 
time using swabs (131 ± 32 vs. 45 ± 14 µM, p = 0.024). This suggests that nitrite in saliva 
may bind to the swab itself or to other components of saliva that bind to the swab, 
resulting in an artifact of low absolute nitrite concentrations. Nevertheless, the 
measurement of nitrite in saliva collected in the swabs provides a relative comparison of 
newborn and adult concentrations where collection of expectorated samples from infants 
is not possible. Improved methods of neonatal saliva collection in the future may lead to 
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more precise determinations of absolute concentrations in neonatal saliva. It is also 
important to note that although our findings indicate that nitrate reducing activity is 
markedly less in the mouths of infants compared to adults despite the PCR detection of 
nitrate reducing bacteria, the PCR results cannot be used as a quantifiable comparison of 
bacterial abundance in infant and adult mouths due to the method of sample collection 
and overnight culture prior to DNA isolation. 
 
Clinical Perspective 
 Hypoxia and ischemia play key roles in several diseases of the newborn period. 
Because nitrite is protective against hypoxic and ischemic insults, questions arise as to 
the potential role of nitrite supplementation of the newborn infant. Such treatment may be 
particularly beneficial to premature infants who require prolonged periods of intubation 
and mechanical ventilation which has been demonstrated in adults to result in significant 
depletion of intragastric NO, presumably due to marked decreases in saliva production 
and swallowing (31). Necrotizing enterocolitis, the most common gastrointestinal 
disorder to affect premature infants, likely results from a combination of decreased 
gastrointestinal blood flow, breakdown of the mucus barrier lining the lumen of the gut, 
and invasion by pathogenic bacteria (32). Intragastric nitric oxide derived from non-
enzymatic disproportionation of swallowed salivary nitrite counteracts all three of these 
factors in adult animal models (31, 33, 34). However, the gastric pH of newborn infants 
is relatively high compared to adults (35, 36), leading to diminished NO production, 
which may hinder its gastroprotective effects and compound the effects of low levels of 
nitrite ingestion in newborn infants.  
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 Premature infants are also at significant risk of suffering intraventricular 
hemorrhage and episodes of inadequate systemic oxygenation. Circulating nitrite 
provides protection against cerebral vasospasm following subarachnoid hemorrhage in 
baboons (37), and can also increase cerebral blood flow (38) and decrease oxygen 
consumption during hypoxic stress (39). During reperfusion, nitrite is found to protect 
against oxidative stress and to reduce the generation of harmful reactive oxygen species 
(40). Whether these protective effects of nitrite are diminished in neonates due to the 
attenuation of enterosalivary nitrate–nitrite–NO metabolism calls for future study. 
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CHAPTER FOUR 
CHANGES IN PLASMA AND URINARY NITRITE AFTER BIRTH IN 
PREMATURE INFANTS AT RISK FOR NECROTIZING ENTEROCOLITIS 
 
Abstract 
 Plasma nitrite serves as a reservoir of NO bioactivity. Because nitrite ingestion is 
markedly lower in newborns than adults, we hypothesized plasma nitrite levels would be 
lower in newborns than in adults, and that infants diagnosed with NEC, a disease 
characterized by ischemia and bacterial invasion of intestinal walls, would have lower 
levels of circulating nitrite in the days prior to diagnosis. Single blood and urine samples 
were collected from nine term infants and twelve adults, 72 preterm infants every five 
days for three weeks, and from 13 lambs before and after cord occlusion. Nitrite fell 50% 
relative to cord levels in the first day after birth; and within 15 min after cord occlusion in 
lambs. Urinary nitrite was higher in infants than adults. Plasma and urinary nitrite levels 
in infants who developed NEC were similar to those of preterm control infants on Days 1 
and 5, but significantly elevated at 15 and 20 days after birth.  Plasma nitrite falls 
dramatically at birth while newborn urinary nitrite levels are significantly greater than 
adults. Abnormally low plasma nitrite levels do not appear to predispose infants to NEC. 
Yet, active NEC is associated with elevated plasma and urinary nitrite levels. 
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Introduction 
The free radical molecule nitric oxide (NO) plays a key signaling role in a number 
of physiological processes. NO is produced from L-arginine by the action of NO synthase 
enzymes found throughout the body. NO can diffuse readily through tissues to distances 
several cells away from its site of production. However, its half-life in whole blood is 
<10 ms and thus the range of free NO itself is paracrine in nature (1). As a free radical, 
NO can be metabolized by a number of different biochemical pathways. Many of these 
pathways result in nitrogen oxide species that are stable enough to circulate systemically 
yet retain the bioactivity of NO, such as nitrite and nitrosothiols. Other pathways oxidize 
free NO to nitrate. While nitrate is inert in mammalian cells, it can be secreted in saliva 
and converted to nitrite by oral bacteria (2), although this pathway is markedly 
diminished in the newborn compared to the adult (3). These products of NO metabolism 
make up a humoral source of NO bioactivity (see review by Lundberg and Weitzberg 
(4)). Thus, it is now recognized that the overall level of NO bioactivity in tissues is a 
result of not only local NO synthase activity, but also the concentration of nitrogen oxide 
species which may be delivered from other organs via the blood.  
There is accumulating evidence that nitrite plays a role in the regulation of 
cardiovascular homeostasis and responses to hypoxic/ischemic stress. Numerous studies 
have demonstrated the positive effects of increasing dietary nitrate intake and subsequent 
elevation in plasma nitrite concentrations on exercise performance and lowering blood 
pressure (5). Modest increases in blood nitrite levels also confer protection in animal 
models of ischemia/reperfusion injury in the brain, heart, liver, kidney, and lung (6). The 
bioactivity of nitrite results from its conversion to NO by reaction with a number of 
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metal-containing proteins with nitrite reductase activity (7), a reaction that is favored in 
hypoxic/ischemic tissues.  
Infants born prematurely are at increased risk of systemic hypoxia and 
compromised cardiovascular homeostasis during the first few days of life. This 
dysregulation of tissue oxygen delivery is proposed to contribute to necrotizing 
enterocolitis (NEC), a gastrointestinal disease that affects 5 to 14% of infants born 
weighing less than 1500 grams (8). While premature birth is a prominent risk factor, the 
underlying cause of NEC remains unknown. Although there is little evidence to support 
the idea that NEC is caused by a single acute perinatal ischemic event (9), poor 
splanchnic oxygenation and reduced blood flow are associated with increased incidence 
of NEC (10-12), and histological evidence of ischemia is consistently found (13,14). In 
the adult rodent gastrointestinal tract, swallowed salivary nitrite, derived from the 
reduction of salivary nitrate by oral bacteria, confers protection by increasing mucus 
production, improving local blood flow, killing bacterial pathogens, decreasing 
inflammation, and improving epithelial injury (5). The role that nitrate and nitrite play in 
regulating gastrointestinal blood flow in the newborn has not been studied. 
We have previously demonstrated that newborn infants have lower blood nitrite 
concentrations than adults, possibly due to markedly lower levels of nitrate and nitrite 
ingestion (15). Preterm infants in particular ingest 50% less nitrite than term infants (15), 
leading us to hypothesize that nitrate and nitrite levels would be decreased in preterm 
compared to term infants. Furthermore, given animal evidence for the protective effects 
of nitrite in the gastrointestinal tract, we hypothesized infants diagnosed with NEC would 
have lower levels of circulating nitrite in the days prior to diagnosis. We tested this 
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hypothesis by measuring plasma nitrate and nitrite and urine nitrite concentrations in 
preterm infants over the first three weeks of life and making comparisons between infants 
who developed NEC and those who did not. 
 
Methods 
Human protocols were pre-approved by the Loma Linda University (LLU) 
Institutional Review Board and written informed consent was obtained from a parent or 
legal guardian, or from the study subject (adult group). The animal protocol was pre-
approved by the LLU Institutional Animal Care and Use Committee.  
 
Human Protocol 
 The infants studied in this investigation were patients in the neonatal intensive 
care unit or well baby nursery of LLU Children’s Hospital (Loma Linda, California). 
They fell into two groups: term infants born after 37 weeks and with a birth weight more 
than 2500 grams, and preterm infants born at a gestational age less than 32 weeks. 
Preterm infants weighing less than 800 grams were excluded from the study due to 
limitations in the amount of blood that could be collected. Also excluded were infants 
with congenital malformations or chromosomal abnormalities, those small for gestational 
age, intrauterine growth restricted, anemic (Hgb < 11 g/dL) or septic (positive blood, 
urine, CSF cultures). The infants’ gestational age, birth weight, gender, type of feeding 
(breast milk or formula), antibiotic therapy, whether a PDA ligation had been performed, 
and whether indomethacin or a blood transfusion had been given were noted.  
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Blood and urine samples were obtained from the preterm infants between 12 to 24 
hours, and 5, 10, 15, and 20 days of extrauterine life. Within this 20-day period, if an 
infant developed signs and symptoms of NEC (defined as Bell’s stage 2A (16)) an 
additional sample of blood and urine was collected within 24 hours of diagnosis. Samples 
of placental cord blood were collected from term infants following uncomplicated 
cesarean section. Blood (1 ml) and urine (1 to 3 ml) samples were also collected from 
these term infants in conjunction with standard newborn screening tests at approximately 
24 hours of life. Single blood and urine samples were also collected from healthy adults 
(24 to 72 years of age). 
 
Fetal Sheep Protocol 
 Fetal sheep were delivered via C-section at 124 to 126 days of gestation 
(term=145) as part of another study protocol (17). Venous blood samples were collected 
for plasma nitrite measurement before birth and at 15, 60, 120, and 180 min after ligation 
of the umbilical cord. Samples were immediately centrifuged for 60 seconds at 10,000 
rpm and the plasma was decanted, frozen in liquid nitrogen, and stored at -80 C for 
subsequent measurement of nitrite concentrations. 
 
Sample Collection and Handling 
  Blood samples (1 ml each) from newborn infants were collected from an 
indwelling catheter whenever possible; otherwise by heel stick timed so as to coincide 
with routine clinical care (blood glucose measurements, blood gas measurements, weekly 
nutrition labs, newborn screen). Blood was collected from adults by venipuncture of the 
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antecubital vein. The blood was immediately centrifuged for one minute at 10,000g. The 
plasma was stored at -80 C until assay.  
 Urine samples (1 to 3 ml each) were collected by placing a cotton ball into the 
infant’s diaper before urination. Sodium hydroxide (0.1 M) was added to the urine 
sample in a 1:1 ratio v/v to stabilize nitrite, and the sample was then stored at -80 C for 
subsequent nitrite analysis.  
 
Nitrite and Nitrate Assay 
 Urine and plasma nitrite concentrations were measured by triiodide 
chemiluminescence (18), enabling quantification above 10 nM with a precision of ±5 nM. 
Nitrate concentrations were measured by enzymatic reduction of nitrate to nitrite as 
previously described (19).  
 
Statistical Analysis 
An a priori power analysis was performed using G*Power (Heinrich Heine 
University, Dusseldorf, Germany), and indicated that with an effect size of 50%, p<0.05, 
and 80% power, a total of six patients with NEC would be needed to detect a change in 
plasma and urine nitrite levels over time and compared to preterm controls. Data are 
presented as mean ± SEM. Differences between study groups were detected using one-
way ANOVA. A two-way ANOVA was used to compare samples from preterm infants 
with or without NEC. When ANOVA indicated significance, Bonferroni’s post hoc 
analysis was applied to detect differences between sample pairs. A Kruskal-Wallis test 
was used to compare term, preterm, and adult plasma nitrite and nitrate levels due to a 
 79 
large variation in the small number of samples in the term and adult groups. Outlying 
values, likely due to nitrite or nitrate contamination occurring during sample collection, 
were identified and removed using the ROUT method (20) with a Q value of 0.1% (0.1% 
chance of excluding a valid value). For comparisons between preterm infants with or 
without NEC, two-way ANOVA was applied to the Day 1 and 5 data to test whether 
nitrite levels were lower in infants who would go on to develop NEC, and to Days 10, 15, 
and 20 to test whether nitrite levels were different in infants with developing or active 
NEC. All statistical analyses were performed using Prism 6 for Mac OSX (Graphpad 
Software, Inc, La Jolla, CA), except for two-way ANOVA with unequal sample sizes 
which was performed with R (R Foundation for Statistical Computing, Vienna, Austria).  
 
Results 
Nitrite concentrations were measured in blood and urine collected from 79 
preterm infants, nine healthy term infants, twelve adults and twelve cord blood samples. 
Of the 79 preterm infants, six infants developed Bell’s stage 2A necrotizing enterocolitis. 
The time of NEC diagnosis ranged from 9 to 29 days after birth (mean 17 days). Six 
preterm infants without NEC developed sepsis and were excluded from analysis because 
plasma nitrite and nitrate levels have been shown to be elevated in pediatric and neonatal 
patients with sepsis (21-24). One preterm infant died on the 18th day of life with an 
isolated ileal perforation and was excluded from the analyses. Thus, 66 preterm infants 
without NEC were analyzed. The demographics of the patients are provided in Table 5. 
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Table 5. Plasma and urine study preterm patient demographics 
 
Preterm Preterm with NEC Term 
Participants (n) 66 6 9 
Gestational age 
(weeks) 29.6 ± 0.2 28.1 ± 0.9 38.4 ± 0.3 
Birth weight 
(grams) 1349 ± 41 1224 ± 128 2791 ± 282 
Male (n) 
26 5 4 
Female (n) 
31 1 5 
Mean day of 
diagnosis - 17 - 
 
 
Nitrite and Nitrate Concentrations in Infant Plasma 
 Twelve to 24 hours after birth, nitrite concentrations of preterm infants (0.03 ± 
0.01 μM) were lower than term infants (0.08 ± 0.01 μM; p<0.05), cord blood samples 
(0.18 ± 0.01 μM, p<0.001), and adults (0.16 ± 0.01 μM, p<0.001). Plasma nitrite levels in 
term infants tended to be lower than cord blood and adult levels, but post hoc analysis did 
not indicate statistical significance. Plasma nitrite concentrations of preterm infants 
increased significantly during the 20 days after birth (p<0.001, Figure 19A). 
Plasma nitrate concentrations of term infants (16.4 ± 1.5 μM) 12 to 24 hours after 
birth were lower than those of preterm infants (25.3 ± 1.7 μM, p<0.05), cord blood 
samples (33.1 ± 3.5 μM, p<0.01), and adults (33.4 ± 3.1 μM, p<0.01) (Figure 19B). One-
way ANOVA indicated that there was significant variation in plasma nitrate 
concentrations of preterm infants over the first 20 days after birth (p=0.014).  
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Figure 19. Plasma nitrite and nitrate and urine nitrite concentrations. A) Plasma nitrite 
concentrations were significantly higher in adults, cord blood, and term infants than in 
preterm infants on the first day after birth (*=difference from preterm infants on Day 1, 
p<0.05). Nitrite concentrations increased over the first 20 days after birth, with Days 10, 
15, and 20 greater than Day 1 (**=p<0.01). B) On Day 1, plasma nitrate concentrations 
in term infants were significantly lower than those of adults, cord blood, and preterm 
infants (* =difference from term infants, p<0.05). The variation in preterm nitrate levels 
over the first 20 days after birth was also significant (p<0.01), although post hoc analysis 
did not detect a significant difference between Day 1 and any subsequent time point. C) 
Urine nitrite concentrations in preterm and term infants on Day 1 were significantly 
higher than those of adults (**=p<0.001). Urinary nitrite concentrations of preterm 
infants increased over the first 20 days of life, with concentrations on Days 15 and 20 
being significantly greater than Days 1 and 5 (* =p<0.05). 
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Nitrite Concentrations in Newborn Lambs 
  The markedly lower nitrite concentrations on the first day after birth led us to 
examine the time course of changes in plasma nitrite concentrations in more detail in 13 
newborn lambs. Prior to ligation of the cord, plasma nitrite concentration in umbilical 
arterial blood was 0.16 ± 0.01 μM. Fifteen minutes after birth, nitrite concentrations had 
fallen to 0.06 ± 0.01 μM (p<0.001), and remained low for at least 180 minutes (Figure 
20). 
 
Figure 20. Plasma nitrite concentrations in fetal sheep before and after ligation of the 
umbilical cord and initiation of ventilation. Within 15 min following birth, nitrite 
concentrations had fallen by >60% (*=p<0.001 compared to baseline) and remained 
lower than baseline 60, 120, and 180 minutes after birth. 
 
 
Nitrite Concentrations in Urine 
  On the first day after birth, urinary nitrite concentrations averaged 0.49 ± 0.05 
μM in preterm infants and 0.50 ± 0.05 μM in term infants, values not significantly 
different from one another (Figure 19C). The levels in both preterm and term infants on 
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Day 1 were significantly higher than the levels measured in urine collected from adults 
(0.07 ± 0.01 μM, p<0.001). In preterm infants, the urine nitrite concentrations increased 
significantly over the first 20 days after birth (p<0.01, Figure 19C).  
 
Plasma Nitrite and Nitrate Concentrations in Preterm Infants with and without NEC  
 Plasma nitrite and nitrate concentrations in those preterm infants who developed 
NEC were not significantly different than those of control preterm infants on Days 1 and 
5. On Days 10, 15 and 20, plasma nitrite concentrations were higher in preterm infants 
who developed NEC than in control preterm infants, with post-hoc analysis indicating 
significance between the two groups on Days 15 and 20 (p<0.05, Figure 21A and B). 
Plasma nitrite concentrations of preterm infants with NEC increased over the first 20 
days after birth (p<0.01). Although plasma nitrate concentrations tended to increase in 
infants with NEC, this change did not meet the criteria for significance (p=0.09). 
Individual and mean plasma nitrite and nitrate concentrations on days relative to 
diagnosis with NEC are shown in Figure 22 A-D. 
 
Urine Nitrite Concentrations in Preterm Infants with and without NEC 
  On Days 10, 15, and 20, plasma nitrite concentrations were higher in the preterm 
infants who developed NEC than in control preterm infants, with post hoc analysis 
indicating significance on Days 15 and 20 (p<0.01). Urine nitrite concentrations of 
preterm infants with NEC increased over the first 20 days after birth (p<0.001) (Figure 21 
C). Individual and mean urine nitrite concentrations on days relative to diagnosis with 
NEC are shown in Figure 22 E and F.  
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Figure 21. Plasma and urine nitrite concentrations in preterm infants with or without 
diagnosis of NEC. There were no significant differences between preterm infants with 
NEC (black bars) or without NEC (white bars) with respect to plasma nitrite (A) or 
nitrate (B) concentrations on Days 1 and 5. In contrast, on Days 10, 15, and 20, plasma 
nitrite and nitrate levels were higher in preterm infants diagnosed with NEC compared to 
those without NEC. C) Fifteen and 20 days after birth, urine nitrite concentrations in 
preterm infants who developed NEC were significantly higher than those of control 
preterm infants (*=p<0.001). Nitrite concentrations in urine from the preterm infants with 
NEC increased over the first 20 days after birth, with levels on the day they were 
diagnosed with NEC (mean=Day 17) being significantly higher than the levels measured 
in these infants on Days 1 and 5 (**=p<0.05). (*=difference from non-NEC infants at the 
same time point, p<0.05; †=difference from Day 1, p<0.05). 
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Figure 22. Plasma nitrite and nitrate concentrations and urine nitrite concentrations in 
preterm infants with a diagnosis of NEC. X-axis shows days relative to the day of 
diagnosis with Bell’s Stage II NEC (Day 0). Each curve represents an individual patient 
in figures A, C, and E, where NEC 1 (●), NEC 2 (■), NEC 3 (●), NEC 4 (■), NEC 5 (□), 
and NEC 6 (●). Figures B, D, and F are the mean (± SEM) data from all patients with 
NEC ( ). 
 
 
 
 
 86 
 
Discussion 
The current study tested the hypotheses that plasma nitrite levels fall significantly 
at birth, that levels in preterm infants fall below those of term infants, and that infants 
diagnosed with NEC would have lower levels of circulating nitrite in the days prior to 
diagnosis. We found that the plasma nitrite concentrations of preterm infants on the first 
day of life were lower than those of term infants, adults and placental cord blood, a 
difference also observed to appear in newborn lambs within 15 minutes after birth. 
Contrary to our hypothesis, plasma and urine nitrite levels of preterm infants who 
developed NEC were similar to those of their non-NEC counterparts on Days 1 and 5 
after birth. Once NEC became apparent, plasma and urine nitrite concentrations were 
measurably higher than those of non-NEC counterparts 15 and 20 days after birth.  
 
Decrease in Plasma Nitrite and Nitrate Concentrations at Birth 
  Several reasons might account for the marked decrease in plasma nitrite in the 
minutes and hours after birth. Previous studies have shown that up to 70% of plasma 
nitrite is derived from NO produced by eNOS (25). Several studies have assessed the 
effects of development on organ-specific eNOS levels (26, 27), but, to our knowledge 
none have measured whole body eNOS activity in newborns. Preterm infants are 
deficient in arginine which could lead to decreased NO synthesis from eNOS (28). 
Neonates also have two- to threefold higher concentrations of asymmetric 
dimethylarginine (ADMA), an endogenous inhibitor of NOS, compared to adults (29). 
Thus, low L-arginine and increased ADMA concentrations may lead to low eNOS 
activity in newborns, contributing to the fall in plasma nitrite levels after birth. 
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It is also possible that the mother and placental tissue constitute a significant 
source of fetal nitrite that is lost at birth. We have previously reported that nitrite 
concentrations of chronically instrumented fetal sheep are the same as those of the 
mother under normoxic conditions, but become two-fold higher than the ewe following 
long term exposure to moderate hypoxia (18). This finding suggests transport of nitrite 
from the ewe into the fetus, production of nitrite by placental tissue, or an accelerated rate 
of nitrite production in the fetus in response to hypoxia. These possibilities have not been 
evaluated experimentally but could influence the changes that occur soon after birth.  
Although most plasma nitrite is derived from NO oxidation, this reaction is only 
one of a number of competing reactions by which NO is consumed. One of the fastest of 
these competing pathways is the reaction of NO with superoxide to form peroxynitrite. 
This reaction proceeds at a nearly diffusion-limited rate (k = 4.3 to 20 × 10 9 M -1 ∙s-1) (30) 
and can become a significant scavenger of NO if superoxide concentrations are increased 
(31). While we are not aware of reported changes in whole body superoxide levels at 
birth, it is reasonable to hypothesize that the increases in arterial and tissue oxygen 
tensions that occur in the transition from fetus to newborn increase superoxide production 
that, in turn, scavenges NO away from nitrite production. 
Regardless of the mechanism, the fall in nitrite levels at birth appears to be 
consistent with other cardiovascular homeostatic events that facilitate the vascular 
transition from a fetal state characterized by low pressures and high flows to a newborn 
state with higher overall resistance to blood flow. Factors that contribute to the increased 
vascular tone of the newborn include decreases in circulating vasodilators such as 
prostaglandin E2 (32) and adenosine (33), and increases in vasoconstricting 
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catecholamines (34). Given the vasodilatory and NO-like bioactivity ascribed to nitrite 
(see review by Lundberg and Weitzberg (4)), the fall in concentrations within minutes of 
birth raises the possibility that nitrite may also play a role in the transition. 
While circulating nitrate concentrations are of cardiovascular relevance to the 
adult due to its conversion to nitrite (35), the same may not be true for newborns as the 
activity of oral nitrate-reducing bacteria is markedly reduced (3). Plasma nitrate 
concentrations tended to decrease at birth, in parallel with nitrite concentrations, although 
the changes were less pronounced in the preterm infants. This may reflect the 
contribution of non-NO-related influences, such as denitrifying enzymes in the liver (36) 
or decreased renal excretion.  
  
Nitrite Concentration in Urine 
  Although there are numerous reports of combined nitrite/nitrate concentrations in 
newborn urine (see Honold et al for comprehensive measurements (37), we are unaware 
of previous reports of urine nitrite levels in healthy infants. Urinary nitrite concentrations 
are typically less than 5% of the total nitrite/nitrate signal, thus the combined nitrite and 
nitrate level is not a useful indication of nitrite excretion. In fact, in contrast to our 
finding of higher urinary nitrite levels in infants compared to adults, Honold et al. 
reported higher urinary nitrite/nitrate concentrations in adults compared to preterm and 
term infants (37). Using the body weights of our infants and estimates of normal urinary 
output (48 mL·kg-1·day-1), one may calculate a urinary nitrite output for preterm infants 
of 3.6 µg·kg-1·day-1 and for term infants of 5.3 µg·kg-1·day-1. A similar calculation for a 
typical 70 kg adult with a urine output of 12 mL·kg-1·day-1 indicates a urinary nitrite 
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output of only 0.24 µg·kg-1·day-1, about 5-10% of newborn output. This marked 
difference between newborns and adults cannot be explained by dietary intake, since 
newborns ingest less than 1% as much nitrite as adults when normalized to body weight 
(38). Interestingly, for newborns the urinary excretion of nitrite is significantly higher 
than their estimated dietary intake (~0.7 µg·kg-1·day-1) (38), whereas excretion by adults 
is less than intake (109 µg·kg-1·day-1) (39). This result suggests net endogenous 
production of nitrite by newborns and consumption by adults. Nitrite is actively 
reabsorbed in the kidney of adults via a pathway dependent upon carbonic anhydrase 
activity (40), and a deficiency in this pathway in newborns would also contribute to 
higher urinary nitrite levels, although this possibility remains to be studied. 
 
Possible Role for Nitrite in NEC 
  Various lines of evidence suggest NO and nitrite potentially play a protective role 
against NEC. L-arginine supplementation to promote eNOS activity has been shown to 
reduce the severity and risk of NEC (41, 42). Nitrite, serving as a source of NO, protects 
against ischemia/reperfusion injury in a number of organs and animal models (6). In the 
gastrointestinal tract, NO derived from nitrite also protects against bacterial pathogens 
and supports thickening of the protective mucosal layer, and thus may support the barrier 
function of the gastrointestinal lining (5). Supplemental dietary nitrite is also protective in 
a mouse model of NEC (43). Thus, our hypothesis was that preterm infants with lower 
plasma nitrite levels during the first few days of life would be more likely to develop 
NEC. However, plasma nitrite levels of preterm infants destined to develop NEC were 
similar to healthy preterm controls, indicating that NEC is not caused by plasma nitrite 
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levels that are lower than normal for a preterm infant. Notably, plasma nitrite levels were 
already markedly lower in preterm infants than in term infants and adults, and whether 
supplementation of nitrite would be protective requires further study. 
 In contrast to the proposed beneficial effects of nitrite and NO under 
physiological conditions, it appears that once NEC has reached an acute inflammatory 
stage, it has been postulated that excessive NO production from inducible NOS (iNOS) 
contributes to the disease progression (44). Resected sections of intestine from infants 
with acute NEC have increased levels of iNOS and iNOS knockout mice appear to be 
protected against LPS-induced bacterial translocation (45). Overproduction of NO by 
enhanced iNOS activity leads to toxic levels of reactive nitrogen oxide derivatives, like 
peroxynitrite, that are thought to contribute to the epithelial injury and disruption of 
repair mechanisms that lead to intestinal barrier failure characteristic of NEC (46). 
Consistent with overproduction of NO by iNOS, plasma nitrite and nitrate and urinary 
nitrite levels in infants developing NEC became significantly elevated fifteen and twenty 
days after birth (Figure 21), suggesting that urinary nitrite levels could be a useful non-
invasive biomarker of NEC. However, more rigorous studies need to be done to validate 
nitrite as a reliable marker for NEC. While the cause of this increase cannot be 
determined from the present study, it is worth noting that similar increases in urinary 
nitrite and/or nitrate are found in infants with systemic inflammatory responses (47), 
consistent with markedly increased iNOS activity.  
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Clinical Perspective 
  The current study finds that a marked fall in circulating nitrite concentrations 
occurs at birth. Given increasing evidence that nitrite plays a key role as a circulating 
source of NO, future studies are needed to establish the extent to which changes in nitrite 
concentrations contribute to the cardiovascular transition at birth, and whether 
manipulation of these concentrations might improve outcomes in infants exposed to 
hypoxic/ischemic stress. 
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CHAPTER FIVE 
DISCUSSION 
 The discovery that nitric oxide (NO) is produced endogenously by NO synthases 
initiated a paradigm shift from thinking of NO as a toxic gas to the realization that it is a 
key regulator of vascular homeostasis, amongst many other physiological roles. One of 
the greatest clinical impacts of this discovery has been the use of inhaled NO gas for the 
treatment of persistent pulmonary hypertension in newborns where it has significantly 
reduced the need for extracorporeal oxygenation (1-2). Initially it was thought that the 
effects of inhaled NO would be confined to the lungs, as free NO gas in blood is 
scavenged by reactions with hemoglobin in a few milliseconds (3). However, it is now 
widely reported that inhaled NO has an array of extrapulmonary effects, suggesting that 
one or more of its metabolites serve as reservoirs of NO bioactivity capable of circulating 
from the lungs to peripheral organs. The existence of such an endocrine mediator of NO 
and its effects would be of great physiological relevance and much recent research has 
focused on identifying metabolites of NO that may serve in that role.  
 Nitrate (NO3-) and nitrite (NO2-) are the two major end products of NO 
metabolism. Historically, these compounds were considered to be relatively inert at 
physiological concentrations and environmental pollutants that posed potential health 
risks to humans at high concentrations. However, similar to the turnabout course of our 
understating of NO in biology, evidence now indicates that while nitrate and nitrite may 
be toxic at high concentrations, they play an important physiological role as they can be 
converted back into NO via a system involving enterosalivary recirculation, bacterial 
nitrate reductases, and enzyme-catalyzed or acidic reduction of nitrite to NO. This 
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discussion will summarize our current knowledge regarding the bioactivity of nitrate and 
nitrite in adults and will outline known differences in infants (summarized in Figure 23 
and Table 6).  
 
 
Figure 23. Schematic summary showing major differences in the supply and handling of 
nitrite and nitrate by the adult and infant. Multiple deficiencies in the infant lead to 
diminished nitric oxide (NO) bioactivity in the stomach and lower circulating nitrite 
concentrations in the blood. 
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Table 6. Summary of the major differences in the supply and handling of nitrite and 
nitrate in adults and infants 
 Adults Infants References 
Dietary nitrate 
ingestion 
0.88-5.83 mg·kg -
1·day -1 
0.07-2.065 mg·kg -
1·day -1 
4-8 
 
    
Saliva nitrate 
concentrations 
190-1600 µM 
a
 
 
681 ± 184 µM b 
190-1600 µM 
a
 
 
284 ± 83 µM b 
9-13 
 
14 
    
Saliva nitrite 
concentrations 
90-670 µM a 
 
50 ± 13 µM b 
 
 
8.2 ± 5.6 µM b 
9-13 
 
14 
 
Saliva production 43-1728 mL/day 43-58 mL/day 15 
    
Oral bacterial nitrite 
production 
147 ± 36 nmoles·min-
1·mg saliva -1 
20 ± 8 nmoles·min-
1·mg saliva -1 
14 
    
Stomach pH 1.5-3.5 3-6 15-18 
    
Gastric NO 
production 
16.4 ± 5.8 ppm c 
89.4 ± 28.6 ppm d 
 19 
  1.53 ± 3.1 ppm 
 
20 
Plasma nitrite 
concentrations 
0.27 ± 0.01 µM 0.18 ± 0.01 µM 21 
    
Urinary nitrate/mmol 
creatinine 
71 ± 10/75 ± 11 
µmol nitrate/mmol 
creatinine 
150 ± 31/136 ± 28 
µmol nitrate/mmol 
creatinine 
22 
a
Saliva collected via expectoration  
b
Saliva collected via oral swab  
c
Basal  
d
After dietary nitrate load 
 
 
Diet 
Dietary Nitrate and Nitrite 
 Nitrate is the most prevalent nitrogen oxide species in the body. Although some of 
it is derived as an end product of the oxidation of endogenous nitric oxide and nitrite, 
nitrate concentrations are also heavily influenced by dietary intake. Nitrate itself is inert 
in mammalian tissues, but it can be reduced to nitrite by symbiotic bacteria that are part 
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of the normal flora in the mouth and gastrointestinal tract (discussed below). Thus, by the 
action of these bacteria, dietary nitrate contributes to the body’s pool of nitrite. 
Vegetables are the most common source of dietary nitrate with particularly high 
concentrations (>2500 mg/kg) in beets, radishes, celery and green leafy vegetables such 
as lettuce, kale, and spinach. Although daily nitrate ingestion can vary significantly 
dependent upon the types and amount of vegetables eaten, it is estimated that a typical 
adult ingests approximately 0.7 to 3.0 mg/kg body weight of nitrate per day (23). 
 Compared to nitrate, the amount of nitrite ingested in a normal adult diet is 
relatively small. In fact, it is likely that more of the nitrite in the body is derived from the 
bacterial reduction of nitrate and oxidation of endogenously-produced NO than from the 
diet (24, 25). The biggest source of nitrite in the diet is cured and processed meats, where 
it is used as an additive to prevent bacterial growth and enhance the color. A typical adult 
ingests about 0.1 mg/kg body weight of nitrite daily (4). 
 Although there are some discrepancies in the reported concentrations of nitrate 
and nitrite in breast milk and artificial milk (perhaps due to differing assay 
methodologies), we and others have recently shown that newborn infants ingest markedly 
lower amounts of nitrate and nitrite than adults on a per kg body weight basis. This is true 
regardless of whether they are receiving breast milk, artificial milk, or parenteral nutrition 
(7, 26, 27). Based on a breast milk intake of 150 mg•kg-1•day-1 and our measurements of 
nitrate and nitrite concentrations (13 μM and 0.13 μM, respectively), we have estimated 
that infants ingest approximately 0.12 mg•kg-1•day-1 of nitrate and 0.0007 mg•kg-1•day-
1 of nitrite from fresh breast milk, which equates to only 5% and 0.6% of the nitrate and 
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nitrite intake of adults (27). A comparison of the average dietary nitrate intake in 
newborn infants and adults is shown in Figure 24. 
 
                    
 
Figure 24. Dietary nitrate and nitrite levels for newborns and adults. A) Daily dietary 
nitrate ingestion, normalized for body weight, is shown for newborns and adults, based 
on a mean (±SEM) of reported concentrations in breast milk and formula (for newborns) 
(7, 26, 27) and a typical adult diet (Mensinga). B,C) Nitrate and nitrite concentrations in 
total parenteral nutrition (TPN), fresh and freeze-thawed breast milk, freeze-thawed 
colostrum, and a convenience sample of artificial milk formulas. (Figure adapted from 
Jones et al., 2014 (27).) 
 
 
 
 We have also shown that nitrite is oxidized to nitrate in breast milk by an enzyme 
normally present in milk, lactoperoxidase, leading to even lower levels in milk that has 
been allowed to sit at room temperature or which has been freeze-thawed (27). Breast 
milk nitrite concentrations also fall during the first few weeks of life, with the highest 
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levels found in colostrum and decreasing to nearly undetectable amounts in milk 
collected after the third week postpartum (26, 27). The levels of nitrate and nitrite in 
artificial milk vary widely across a range that extends above and below concentrations 
measured in breast milk, averaging 43 μM and 0.3 μM, respectively (27) (Figure 24). The 
recently increased use of nutritional additives for caloric and protein enhancement raises 
the possibility of an additional source of dietary nitrate and nitrite, although to our 
knowledge concentrations in these additives have not yet been reported. Whether the 
newborn deficiency of dietary nitrite and nitrate serves an important physiological role, 
or whether supplementation of breast milk with these anions would be beneficial or 
problematic remains to be studied. 
 Until recently, a majority of research related to dietary nitrate and nitrite was in 
the context of toxicology. It has been known since 1945 that unusually high nitrate 
concentrations in vegetables and drinking water, often due to contamination with 
fertilizer, can cause cyanosis due to oxidation of hemoglobin to methemoglobin by nitrite 
derived from bacterial nitrate reductases, a problem often referred to as “blue baby 
syndrome.” Newborn infants are particularly susceptible to this problem as they have 
~25% lower methemoglobin reductase activity than adults (28). It is also proposed that 
dietary nitrate and nitrite are associated with gastrointestinal cancer due to the formation 
of carcinogenic N-nitroso compounds. Although a definitive causal link between dietary 
nitrate and cancer has not been identified (29), the associations between the intake of 
nitrite-treated meats and gastric cancer are more established (30). This is consistent with 
evidence that nitrite added to meats as a preservative can be converted to harmful N-
nitrosamines in the meat itself before ingestion or in the body after it has been ingested 
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(31). In an effort to protect against toxicity, the Environmental Protection Agency (EPA) 
has set limits on inorganic nitrate and nitrite levels in drinking water and the World 
Health Organization (WHO) has put forward Acceptable Daily Intakes (ADI) for nitrate 
at 3.7 mg/kg of body weight and for nitrite at 0.06 mg/kg of body weight. These levels 
are easily exceeded, however, with a high vegetable diet, and some have called for a 
resetting of these limits based on recent advances in our understanding of the roles of 
dietary nitrate and nitrite (26). The upper limits of toxicity of dietary nitrate in newborns 
have been investigated. Phillips, et al. found that up to 21 mg/kg of nitrate per day was 
well tolerated by seven newborn infants, with six infants showing no increase in 
methemoglobin and the other one only a slight increase, and not enough to produce 
detectable cyanosis. Likewise, no symptoms of cyanosis occurred even when 100 mg 
nitrate •kg-1•day-1 was given to an infant for 8 days (32).  
 In contrast to the evidence of the toxic effects of nitrate and nitrite, the data 
increasingly indicates that a diet rich in nitrate is beneficial to overall cardiovascular 
health. In adults, raising dietary nitrate intake has been shown to improve exercise 
tolerance (30, 33, 34), decrease blood pressure (24, 34), inhibit platelet aggregation (24), 
decrease risk of cardiovascular disease (35), and improve vascular compliance (36) (see 
Weitzberg, 2013 for a comprehensive review) (37). In addition, nitrite supplementation 
ameliorates microvascular inflammation and endothelial dysfunction in mice fed a high-
cholesterol diet (38). Dietary nitrate also appears to have beneficial effects in the 
gastrointestinal tract of adult rats, where it has been shown to protect against non-
steroidal anti-inflammatory drug (NSAID)-induced ulcers (39). Weighing the beneficial 
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effects of increasing dietary nitrate and nitrite (37) against the potential risks of 
methemoglobinemia and carcinogenicity is the focus of ongoing studies. 
 
Saliva 
 In addition to dietary intake of nitrate and nitrite, the levels of these anions in 
swallowed saliva also have a significant impact on the amount of nitrate and nitrite that is 
ingested. As discussed in this section, this appears to be another point of significant 
difference between adults and newborns, thus compounding the effects of low dietary 
nitrate and nitrite ingestion in newborns.  
 
Bacterial Conversion of Salivary Nitrate to Nitrite 
 Fasting nitrate concentrations average about 200 µM in the saliva of adults but 
can reach as high as 10 mM after a nitrate-rich meal (12). These concentrations are 
approximately 10-fold higher than the concentrations measured in plasma due to active 
transport of nitrate from the blood into the saliva by the salivary glands. The transport of 
nitrate has been suggested to be mediated by the enzyme sialin via an ATP-dependent 
electrogenic NO3-/H+ transport mechanism in the salivary acinar cells (40). The nitrate 
concentration in the saliva of newborns is approximately 200 µM, similar to that of adults 
(14). As in adults, this concentration is many-fold higher than in blood (16-40 µM). Thus 
the active transport mechanisms in the salivary glands of newborn infants are present 
with a concentrating power comparable to that of adults (21, 41). That the body expends 
energy to actively concentrate nitrate into the saliva suggests that nitrate is not just an 
inert end product of NO metabolism, but has potential bioactivity in the body.  
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 Although nitrate itself appears to be inert in mammalian tissues, it is made 
physiologically relevant after reduction to nitrite by bacteria residing in the crypts of the 
dorsal posterior surface of the tongue. These bacteria utilize nitrate as the terminal 
electron acceptor in the respiratory chain, rather than oxygen and reduce about 20% of 
salivary nitrate in adults (30, 42). A true symbiotic relationship between these bacteria 
and the human host exists as humans lack the requisite enzymes to bring about this 
conversion independently but provide nitrate to the bacteria that then perform nitrate 
reduction via respiration. As discussed below, these nitrate-reducing bacteria are critical 
to the beneficial effects of dietary nitrate.  
 The primary bacteria that mediate nitrate reduction in the mouth are obligate 
anaerobes of the Veillonella species and facultative anaerobes of the Actinomyces, 
Rothia, and Staphylococcus species, all of which possess nitrate reductase enzymes that 
allow them to respire nitrate and rapidly produce nitrite (43). Veillonella and Actinomyces 
species have been found in saliva collected from infants in the first two months of life 
and appear to be some of the first bacteria to colonize the mouths of newborns (12, 44-
46). Despite the presence of these bacteria, oral nitrate reductase activity is markedly 
lower in newborn infants when compared to adults, as shown in Figure 25. It is unknown 
whether this difference comes from insufficient numbers of bacteria, whether the bacteria 
do not possess sufficient nitrate-reducing capacity, or whether the mouth of newborns 
lack some cofactor for nitrate reduction or some other necessary element.  
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Figure 25. Nitrate-reducing activity, normalized for saliva weight, in swab samples 
collected from the mouths of preterm (born at <35 wk gestation) and term (born at >36 
wk) infants in the neonatal intensive care unit (NICU) or from healthy infants in an 
outpatient clinic between 2 and 6 wk after birth, or from normal healthy adults. 
Mammalian cells lack the enzymes required for nitrate reduction, but bacteria dwelling in 
crypts of the tongue bring about the reaction. Note that the rate in infants is ~10% of that 
in adults. (Figure adapted from Kanady et al., 2012 (14).) 
 
 By measuring the nitrate-reducing capacity of bacteria in oral swabs collected 
from infants, we have shown that there is essentially no detectable nitrite production from 
nitrate in the first five days of life. While there is measurable nitrate reducing capacity in 
swabs collected from infants at two to eight weeks of age, the rate of nitrite production is 
only ~10% of that of adults (14), as illustrated in Figure 25. Notably, infants also produce 
relatively small volumes of saliva during the first few weeks of life, which may attenuate 
bacterial growth and may also result in less swallowed salivary nitrite compared to the 
adult (14). The developmental time point at which the nitrate reducing capacity of the 
infant mouth becomes comparable to the adult is unknown.  
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 The diminished bacterial nitrate reducing capacity in infants may be of 
physiological relevance because salivary nitrite impacts both gastrointestinal and 
cardiovascular function in adults. Blockade of salivary nitrate secretion by ligation of the 
submandibular gland duct in rats results in decreased gastric nitrate, nitrite, and NO 
concentrations and exacerbates stress-induced gastric ulcers (47). The severity of gastric 
ulcers in these rats is reduced upon supplemental nitrate treatment (47). These 
gastroprotective effects appear to be mediated through the action of increased salivary 
nitrite, as nitrite-rich saliva results in increased gastric mucosal blood flow, a thicker 
mucus layer, and attenuation of the inflammatory response associated with NSAID 
administration in rats (39, 48-49). These effects of nitrite on the stomach are likely due to 
its conversion to NO, as discussed below. 
 In addition to the effects in the gastrointestinal tract, increasing dietary nitrate, 
and concomitant increases in salivary nitrite, have been shown to decrease arterial blood 
pressure, protect against ischemia-reperfusion induced endothelial dysfunction, and 
decrease platelet aggregation (24, 34). The importance of salivary nitrite production by 
oral bacteria is again highlighted by the finding that if subjects refrain from swallowing 
saliva after a dietary nitrate-load or are given antibacterial mouthwash to decrease 
bacterial nitrate-reducing activity, the hypotensive effects of nitrate are attenuated and 
there is no inhibition of platelet aggregation (24, 50). Increasing dietary nitrate also leads 
to increased circulating nitrite concentrations (24), which is associated with a host of 
beneficial effects ranging from improved exercise tolerance to protection against 
ischemia-reperfusion injury (discussed below).  
 107 
 Thus, considering the beneficial gastrointestinal and cardiovascular effects of 
dietary nitrate and subsequent salivary nitrite production by oral nitrate reducing bacteria 
in adults, the lack of the critical bacterial nitrate reduction in infants is noteworthy and 
deserves investigation. Moreover, the lack of bacterial nitrate reducing activity in infants 
will compound the already low levels of nitrate and nitrite in their diet, ultimately leading 
to significantly lower nitrite delivery to the infant stomach. The potential benefit of 
adding a mother’s oral bacteria to an infant’s mouth is untested. 
 
Gastrointestinal tract 
Intragastric Conversion of Nitrite to NO 
 In 1994, two independent studies showed that NO was generated from nitrite in 
the stomach of human adults (51, 52). These studies showed a novel nitric oxide synthase 
(NOS)-independent in-vivo mechanism by which NO could be generated from nitrite. 
Since then, there has been great interest in nitrite as not merely an inert NO metabolite 
but as a physiologically relevant source of NO bioactivity. The chemical reaction by 
which NO is generated in the acidic stomach of adults involves protonation of nitrite to 
form nitrous acid (pKa 3.3), which rapidly decomposes to several highly reactive 
nitrogen oxides, including NO free radical, NO2, N2O3, and peroxynitrite (51, 53). In the 
stomach, these nitrogen oxides can form new stable products through nitration and 
nitrosylation of amines, amides, thiols, and fatty acids. These products have wide-ranging 
bioactivities, which include modulation of inflammatory signaling pathways, inhibition 
of platelet aggregation, vasodilation, mucus production, and bacterial colonization, 
among many other functions (53-56). 
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 Via gastric conversion to NO, ingested nitrite has been shown to kill many 
different enteropathogens including Salmonella, Shigella, H. pylori, E. coli, Yersinia 
enerocolitica, C. difficile and Candida albicans, establishing nitrite as a key player in 
host defense (57-60). In addition to acting as a bactericidal agent, NO plays a key role in 
host defense in the gastrointestinal tract by stimulating mucus and fluid secretion, 
regulating the epithelial barrier, mediating vascular smooth muscle tone, diminishing 
leukocyte adherence to the endothelium, modulating mucosal repair, and influencing the 
release of inflammatory mediators (57,61). While it is now apparent that nitrite-derived 
NO plays many protective roles in the stomach and GI tract, it is important to note that 
nitrite in the stomach (via conversion to nitrous acid and other nitrogen oxides) can also 
act as a nitrosating agent, converting ingested amines into their carcinogenic N-nitroso 
derivatives (30). However, while the nitrosating ability of acidified nitrite is clear, there is 
still no direct evidence that increased ingestion of nitrate, and subsequent conversion to 
salivary nitrite and gastric NO, causes increased risk of gastric cancer (42).  
 NO generation from nitrite in the stomach is highly pH dependent and is 
effectively attenuated with proton pump inhibitors (52). Consequently, the protective 
effects of swallowed nitrite appear to be highly dependent upon gastric acidity as 
increasing the pH above a value of 4 effectively prevents nitrite-induced increases in 
blood flow (48) and reduction in pathogenic bacteria (51, 60), and blocks nitrite’s 
hypotensive effects (62).  
 The pH dependence of nitrite-derived gastric NO is of particular relevance in the 
newborn, as the newborn stomach has a relatively high pH compared to the adult stomach 
(17, 18, 63). Figure 26 illustrates the effect of pH on the rate of NO production from 
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nitrite using previously calculated rate constants (64). As shown in Figure 26, the less 
acidic environment of the newborn stomach would attenuate the generation of NO from 
nitrite delivered to the stomach, compounding the already low nitrite ingestion from the 
saliva and diet. In fact, non-enzymatic NO production in the stomachs of newborns 
averages 1.53 ± 3.10 ppm (20), as compared to 16.4 ± 5.8 ppm in fasted adults (19) or 
89.4 ± 28.6 ppm after a 2 mmol nitrate load (19).  However, reports vary as to the 
quantitative amount of stomach NO generation in adults, which are also reported as low 
as 0.6 ± 0.1 ppm in fasted adults and 1.64 ± 0.4 ppm after dietary nitrate intake (52). 
Interestingly, peak gastric NO generation is shown to be lower in formula-fed infants 
(2.24 ± 15.71 ppm) versus breastfed infants (6.03 ± 5.73 ppm) (20). Further work should 
be done to explore these intriguing findings.  
 High gastric pH in newborns has been associated with an increased risk of 
necrotizing enterocolitis (NEC) (65, 66), whereas low gastric pH protects against 
bacterial translocation across the gut wall in neonatal rabbit pups (67). Considering that 
acidified nitrite kills bacteria, improves mucus secretion and mucosal blood flow, and is 
protective against ischemia-reperfusion injury (discussed below), it is worth speculating 
that enhancing NO generation from nitrite would be protective against NEC. 
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Figure 26. Nomogram showing the rate of nitric oxide (NO) generation in gastric fluid 
for various pH and nitrite concentrations. The adult and newborn ranges of nitrite 
concentrations are shown as box and whisker (min to max) plots of saliva nitrite 
concentrations (14) and placed at reported typical ranges of gastric pH for adults and 
newborns (18). The infant rate is estimated to be about 100-fold slower than the adult rate 
due to less acidity in the newborn stomach and lower nitrite levels ingested. Curves were 
constructed using rate constants and equations given by Zweier et al. (64). 
 
 
Intestine 
 In contrast to the NOS-independent generation of NO in the stomach, NO 
generation in the colon appears to be mediated by NOS-dependent mechanisms, as 
demonstrated by the finding that rats treated with the NOS inhibitor NG-nitro-L-arginine 
methyl ester (L-NAME), have significantly less NO generation in the colon while NO 
generation in the stomach is unaffected (68). In rats, NO concentrations in the stomach 
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(>4000 ppb) are orders of magnitude higher than in the small intestine (<20 ppb), cecum 
(~200 ppb), or colon (<25 ppb) (68). Interestingly, germ-free rats have markedly lower 
NO generation in all areas of the gastrointestinal (GI) tract, including the stomach, 
indicating an important role for bacteria in NO production throughout the GI tract. Germ-
free rats provide a useful comparison to newborn infants, as diminished gastric NO in 
germ-free rats is thought to be due to the lack of oral nitrate reducing bacteria since 
gastric NO production is dependent on substrate (ingested nitrite) availability (68). In the 
cecum, NO is in part formed via reduction of nitrate and nitrite by strains of Lactobacilli 
and Bifidobacteria (69) and stimulation of the mucosal NOS enzymes by GI bacteria 
(68). NO generation in the intestine, either by Lactobacilli farciminis or by administration 
of an NO-donor, has been demonstrated to have anti-inflammatory effects in an animal 
model of colitis (70), highlighting the potential protective effects of increased NO 
generation in the intestine. 
 Given the beneficial effects of NO derived from ingested nitrite on the 
gastrointestinal microbiota, blood flow and mucus production (described above), we were 
interested in nitrite’s role in the context of NEC. NEC is the most common 
gastrointestinal disease to afflict premature infants. It is a disease characterized by 
intestinal barrier failure (71) most likely subsequent to an ischemic insult. The main 
factors contributing to the regulation of gastrointestinal blood flow in the preterm infant 
are poorly defined, and it is not known whether a deficiency in NO contributes to the 
dysregulation of gastrointestinal blood flow that is thought to precede NEC. Thus, we 
hypothesized that infants with NEC would have lower circulating nitrite levels (and thus 
lower NO bioavailability) in the days preceding the onset of NEC. However, we found 
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that abnormally low plasma nitrite levels do not appear to predispose infants to NEC. 
Yet, active NEC (Bell’s Stage II, diagnosable by radiographic signs (72) is associated 
with elevated plasma and urinary nitrite levels. 
 Translocation of bacteria across the compromised gastrointestinal wall leads to 
activation of an inflammatory response characterized by pronounced up-regulation of NO 
production by inducible NOS (iNOS). In this inflammatory stage of the disease, 
overproduction of NO by iNOS results in toxic levels of peroxynitrite, further damaging 
the integrity of the gut wall by inducing enterocyte apoptosis and necrosis, or by 
disrupting tight junctions and gap junctions that normally maintain epithelial monolayer 
integrity (73, 74). Thus, a vicious cycle characteristic of severe NEC is created by 
bacterial invasion, immune activation, uncontrolled inflammation with production of 
ROS and nitrogen species, vasoconstriction followed by ischemia-reperfusion injury, gut 
barrier failure, intestinal necrosis, sepsis and shock (75). Since NEC is predominantly 
found in preterm infants, and preterm infants have significantly lower plasma nitrite 
levels than term infants (0.03 ± 0.01 μM vs. 0.08 ± 0.01 μM; p<0.05), it would appear 
reasonable to hypothesize that NO plays a dichotomous role in NEC, with deficient levels 
of NO contributing to an increased vascular resistance during the initiating ischemic 
event, and subsequent overproduction of NO during the inflammatory stage of the disease 
leading to propagation of the injury. Interestingly, Yazji et al have recently reported that 
nitrite/nitrate-deficient formula predisposes newborn mice to NEC, and that both the 
incidence and severity of NEC was ameliorated by nitrite/nitrate supplementation to the 
formula to achieve levels comparable to that of breast milk (76). However, the clinical 
relevance of this finding is uncertain given the fact that nitrite and nitrate concentrations 
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of many commercially available formulas are already higher than those found in breast 
milk (27). Whether manipulation of the decreased levels of ingested and circulating 
nitrite in the preterm infant would prevent or alter the course of NEC is an area worthy of 
study.  
  
Nitrite Supplementation for the Prevention of NEC in Newborn Rat Pups 
 To test whether nitrite supplementation would be protective against NEC, we 
utilized a newborn rat pup model of NEC, based on that described by Nadler et al. (77). 
In this model, neonatal rats are removed from their mothers after Caesarian-section, 
placed in a humidity and temperature-controlled incubator, gavage-fed formula in lieu of 
breast milk, and exposed to hypoxia (5% O2, 95% N2) twice daily. Littermate controls are 
placed with a foster dam and allowed to breast feed ad lib and are not exposed to 
hypoxia. Using this model, we sought to test the efficacy of nitrite (0-3mM) in preventing 
intestinal damage by evaluating the ileum for signs of NEC. Tissue sections were given a 
score from 0 (healthy) to 4 (severe NEC), with a score of 2 or greater indicating NEC. 
We also evaluated the tissue for macroscopic evidence of pnuematosis intestinalis and 
bowel discoloration.  
 Although this model is used in multiple labs throughout the country and has been 
helpful in elucidating many of the molecular pathways involved in NEC pathogenesis, its 
clinical relevance is limited given that NEC typically manifests 2-4 weeks after birth, 
rather than in the first 72 hours after birth as designed in this experimental model (78). In 
addition to this inherent problem with the model, we experienced difficulty in being able 
to reliably reproduce histological NEC in the pups, as determined by two independent 
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clinical pathologists blinded to the study conditions. Thus, it was impossible to form 
conclusions about nitrite’s efficacy against NEC since NEC could not be shown to be 
induced.  
 Through the use of this model, however, we found that the mean histological 
score of 34 pups that did not receive supplemental NO2- (formula-fed (FF) + hypoxia) 
was significantly worse than that of the healthy control group (0.5 ± 0.08 vs. 0.23± 0.03, 
respectively) (p<0.01, ANOVA). The histological scores of the pups that received nitrite 
were not significantly worse than the healthy controls. However, they were not improved 
compared to the FF + hypoxia group (Figure 27). Furthermore, nitrite treatment had no 
effect on the survival rates, weight gain, severity of pneumatosis intestinalis, or intestinal 
discoloration. Based on the histological scores, nitrite may offer some protection against 
the early stages of intestinal damage. However, the other points of evaluation suggest the 
preventative effects of nitrite are minimal. Moreover, the scores for the FF + hypoxia 
(“NEC” positive control) group did not reach the threshold for NEC and thus, nitrite’s 
efficacy in preventing NEC remains untested. 
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Figure 27. Histological scores of ileum samples collected from neonatal rat pups exposed 
to formula feeding (FF) with increasing doses of nitrite (0-3 mM) and hypoxia twice 
daily for 72 hours.  
 
  
Circulation 
Circulating Nitrite 
 Shortly after the discovery that NO is generated from nitrite in the acidic 
environment of the stomach, Zweier and colleagues showed that NO could also be 
generated from nitrite in ischemic heart tissue (79). Nitrite reduction to NO in hypoxic 
tissues appears to be mediated either by acidic disproportionation (similar to the 
mechanism in the acidic stomach) or by the activity of metal-containing proteins with 
nitrite reducing activity. These proteins include the heme-associated globins in their 
deoxygenated state, such as deoxygenated myoglobin, hemoglobin, cytoglobin and 
neuroglobin, as well as mitochondrial enzymes like complex III; molybdenum 
 116 
metalloenzymes, such as xanthine oxidoreductase (80); cytochrome P450 enzymes; and 
endothelial NOS (see the review by Kim-Shapiro and Gladwin) (81). While the initial 
report by Zweier suggested that nitrite reduction to NO in acidic tissues exacerbates post-
ischemic injury (79), nitrite has since been consistently shown in experimental animals to 
be protective against ischemia-reperfusion (I/R) injury in the heart, brain, liver and 
kidney (82). The mechanism by which nitrite confers protection against I/R injury is not 
well understood, but is thought to involve reduction to NO which modulates the function 
of the mitochondria, leading to more efficient oxygen utilization, decreased reactive 
oxygen species formation, and the inhibition of apoptotic signaling (83). The therapeutic 
potential of nitrite against I/R injury in newborns has not yet been studied. Considering 
that neonates are particularly at risk for hypoxic and ischemic insults, further research is 
needed to address the therapeutic and preventative potential for nitrite supplementation in 
the neonatal population. 
 While nitrite supplementation has yet to be studied in neonatal populations, it has 
been shown that treatment of persistent pulmonary hypertension of the newborn with 
inhaled NO (iNO) increases nitrite levels in the blood at least two-fold (21, 84). Although 
the resulting nitrite concentrations reached only ~300 nM after iNO administration, 
similar increases in circulating nitrite concentrations have been shown to protect mice 
against hepatic infarct (85), increase blood flow in the human forearm (86), and decrease 
systolic blood pressure in adults (24, 34, 87). Thus, increases in circulating nitrite levels 
resulting from iNO treatment may be enough to cause significant systemic effects (21). 
Indeed, there are a number of reports demonstrating protective effects of iNO therapy in a 
mouse model of myocardial infarction (88), adult human liver transplant patients (89), 
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and in children following cardiopulmonary bypass (90). Whether the protective effects of 
iNO are due to elevations in circulating nitrite remains to be determined. 
 Given that nitrite could theoretically improve an infant’s ability to withstand 
ischemic stress, it is important to discuss the mounting evidence that normal newborn 
infants appear to have numerous mechanisms in place that decrease systemic nitrite levels 
during the first few weeks of life. As shown in Figure 23, these mechanisms include low 
dietary nitrite and nitrate intake, the lack of bacterial nitrate reduction in the mouth, a 
relatively high pH in the stomach, enhanced urinary excretion, and a dramatic fall in 
plasma nitrite concentrations at birth.  
 We have shown that circulating nitrite concentrations decrease markedly after 
birth, falling from approximately 0.18 ± 0.02 μM in umbilical cord plasma to 0.08 ± 0.02 
μM in plasma collected from term infants on their first day of life. Interestingly, plasma 
collected from preterm infants has even lower nitrite concentrations (0.03 ± 0.01 μM). 
Plasma nitrite concentrations are significantly lower in infants than those measured in 
adults, which averaged 0.17 ± 0.01 μM in our study and typically range from 50 to 300 
nM (42). Moreover, plasma nitrite appears to remain lower than adult levels for the first 
few weeks of life. These findings are consistent with previous reports that adult plasma 
nitrite levels are significantly higher than those of newborn infants (21), but are similar to 
those in umbilical cord blood (91). The relevance of the dramatic fall in circulating nitrite 
levels immediately after birth is uncertain, but may be an important part of the circulatory 
changes that occur at birth.  
 There are many factors that contribute to plasma nitrite concentrations. In adults, 
a majority of plasma nitrite is derived from the oxidation of NO produced by endothelial 
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NOS (eNOS) (25). This oxidation depends on enzyme-catalyzed reactions in the plasma 
(92), which are significantly attenuated in the newborn (93). In addition, eNOS activity 
may be diminished in newborns due to low levels of L-arginine (94) and increased levels 
of asymmetric dimethylarginine (ADMA), the endogenous inhibitor of NOS (95-97). 
Furthermore, the rapid increase in tissue PO2 that occurs at birth may result in increased 
superoxide levels, particularly in preterm infants who are likely to have low antioxidant 
defenses (98-101). This superoxide can rapidly scavenge NO to produce peroxynitrite 
instead of nitrite. Another potential cause of relatively low plasma nitrite in infants could 
be the lack of significant oral bacterial nitrate reduction, as discussed above and 
illustrated in Figure 25. We have shown that adults given antibacterial mouth rinse have 
significantly reduced plasma nitrite concentrations (14), highlighting the importance of 
the oral nitrate reducing bacteria to the amount of circulating nitrite. Thus, with the 
confluence of all of these factors, it appears that nitrite bioavailability is diminished in the 
newborn by a system of concerted mechanisms, as evidenced by the sharp fall in nitrite 
concentrations at birth. The physiological relevance of this decreased nitrite in newborns 
remains to be elucidated and should be more fully understood before efforts are made to 
study the potentially therapeutic use of nitrite in this patient population. 
 
Summary 
 Before birth nitrate and nitrite concentrations in fetal blood are similar to those in 
maternal blood due to rapid passive exchange of the anions across the placenta. Within 
hours of birth, however, the nitrite concentration in the newborn falls sharply in 
association with increases in blood pressure, increases in pulmonary blood flow, and 
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many other adaptations to increasing oxygen tensions. In the early weeks of life nitrate 
and nitrite levels remain low for several reasons. There is limited ingestion of nitrate and 
nitrite because their concentrations are low in milk and formula. There is little reduction 
of nitrate to the physiologically active nitrite by oral bacteria. There is little generation of 
NO in the newborn stomach because the pH is high.  Finally, there is enhanced urinary 
excretion of nitrite. The net result is that the recirculation of nitrate and nitrite as 
bioactive sources of NO is markedly lower in the newborn than in the adult.  
 In recent decades the many serious concerns that nitrite in the diet would cause 
cancer and methemoglobinemia have lessened and been replaced by new findings of 
cardiovascular benefits. In the newborn period there arises the prospect of protecting the 
GI tract from bacterial invasion by supplementation with nitrite, thereby increasing NO 
bioactivity and its protective actions. However, careful investigation must be done 
weighing the risks against the benefits before supplementation with nitrite can be 
undertaken safely in newborn infants. 
 
Future Directions 
 One of the most exciting things about research is that in trying to answer one 
question, many more questions arise. The continual pursuit of knowledge is what drives 
science forward and it is a humbling honor to have been able to contribute my small piece 
of the puzzle. Our work has raised important questions regarding nitrite and nitrate 
bioactivity in newborn infants and will hopefully lay the groundwork for future studies to 
assess the therapeutic potential of nitrite. Indeed, exciting studies are currently underway 
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in our lab evaluating the protective potential of nitrite against hypoxia in the fetus and 
newborn. 
 It is important that future work explore the physiological effects of diminished 
nitrite and nitrate ingestion in newborn infants. To address the physiological implications 
of chronic low nitrate ingestion, changes could be observed in adults subjected to a low-
nitrate diet. In addition, future work addressing how human milk fortifiers impact the 
nitrate and nitrite levels in breast milk would have important clinical relevance. It would 
also be interesting to see whether maternal consumption of a high nitrate diet could raise 
the nitrate/nitrite content in breast milk and whether this could be beneficial.  
 Every day we learn more about the importance of the symbiotic relationship we 
have with bacteria. Given the importance of oral nitrate-reducing bacteria, future studies 
should identify the age at which oral nitrate reductase activity becomes significant. It 
would also be fascinating to explore how bacterial colonization differs in preterm infants 
in the NICU versus healthy term infants and how early use of broad-spectrum antibiotics 
impact the development of the microbiome. Similarly, studies should be done to 
investigate whether seeding an infant’s mouth with the mother’s saliva would be 
beneficial for normal colonization of flora. In addition, the effects of chronic use of 
antibacterial mouth rinse, in the context of nitrate and nitrite bioactivity, remain untested. 
This has important clinical implications as prophylactic chlorhexidine4 treatment is used 
to prevent the oral complications of leukemia (102), HIV (103), and prolonged intubation 
(104).  
                                                 
4 Chlorhexidine is the antibacterial mouthwash we used to stop nitrate-reducing activity by oral bacteria in 
our studies 
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 In addition to decreased dietary intake and bacterial activation of nitrate, 
decreased gastric NO generation may be another mechanism responsible for the low 
plasma nitrite levels in newborns and the particularly low levels in preterm infants. 
Future studies should explore this important component of the nitrate-nitrite-NO axis in 
newborn infants. As a first step, we collected gastric fluid samples from eleven preterm 
infants (<32 weeks gestation), thirteen infants born between 32-37 weeks gestation (late 
preterm), and seven term infants (>37 weeks gestation). As expected for newborns, the 
average pH of the samples is relatively high (4.4 ± 0.3, preterm; 4.2 ± 0.1, late preterm; 
and 3.9 ± 0.3, term) and is higher than the pKa for nitrite reduction to nitrous acid, which 
is ~3.2. Consistent with the other aspects of the nitrate-nitrite-NO axis, we see that the 
generation of NO from nitrite is greatly diminished due to the high pH of these stomach 
contents. Figure 28 shows the rate of NO generation in gastric residual samples at various 
pHs, highlighting the dramatic decrease in NO production at higher pH.   
 
Figure 28. Rates of NO production from 50 µM nitrite added to gastric residual samples 
(●) and simulated gastric fluid (□) at different pHs. 
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However, we were surprised to find that the nitrite concentrations in these gastric 
residuals are remarkably high in preterm infants (<32 weeks gestation) (10.8 ± 3.6 µM), 
infants born at 32-37 weeks gestation (9.7 ± 2.4 µM), and in term infants (4.5 ± 2.0 µM), 
as shown in Figure 29.  
 
   
Figure 29. Mean nitrite concentrations measured in gastric residual samples collected 
from newborn infants during the first three weeks of life. Each data point represents the 
mean nitrite concentration in all the samples collected from one infant.  
 
These levels are over a 100-fold higher than the plasma and 100-fold higher than 
the levels in breast milk, as shown in Figure 30.  
 One future direction of our work is to explore this exciting finding. We have 
generated a few hypotheses regarding the high nitrite levels in these gastric fluids and 
herein present preliminary results that will be useful for determining future work.  
 
 123 
 
Figure 30. Comparison of the nitrite concentration in the plasma, urine, diet, saliva, 
stool, and gastric residuals of infants. Adult values were included when available. 
 
 Possible reasons for high gastric nitrite in infants include: nitrate reduction to 
nitrite by bacteria, accumulation of breakdown products of breast milk proteins, active 
transport across the stomach mucosa, co-transport of nitrite with protons, concentration 
of nitrite after loss of volume, and diminished reduction of nitrite to nitrous acid and NO 
because of the high gastric pH. 
 Nitrate reduction by bacteria seems unlikely because there is no nitrite production 
after nitrate is added in six of the seven gastric samples measured (Figure 31). Similarly, 
breakdown of milk proteins in an acid solution does not cause an increase in the nitrite 
concentration (data not shown).  
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Figure 31. Nitrate reduction in gastric residual samples. A) After additional nitrate (0.3 
mM) was added to seven gastric residuals (represented by individual lines), nitrite 
concentrations were measured over 30 minutes (similar to the oral bacteria experiments 
described in Chapter 3). B) Mean data represented as % of baseline.  
  
 We have promising data from preliminary studies in adult rats testing the 
possibility that the high pH in the stomach of newborns is preventing nitrite in the 
stomach from being converted to nitrous acid and NO. When 4.0 mL of a high pH buffer 
(10mM bicarbonate buffer, pH 8.4), containing 0.02 mg/ml phenol red (a non-absorbable 
marker for stomach volume measurements) and 10 µM nitrite, was infused into the rat 
stomach, the nitrite concentration remained high over the 30 minutes. Conversely, when a 
low pH buffer (1% pepsin in NaCl and HCl, pH 2.0) was infused into the stomach, the 
nitrite concentrations fell rapidly during the 30 minutes (Figure 32). In both groups, we 
did not see an increase in the nitrite concentration over time despite volume loss, 
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indicating that concentration of nitrite because of loss of water is not a likely explanation 
for the high nitrite levels in the stomach. 
 
Figure 32. Nitrite concentrations in stomach fluid collected from rats after infusion of a 
low or high pH buffer into the stomach. 
  
 One intriguing hypothesis is that nitrite is actively pumped into the stomach from 
the plasma. To test this, in our preliminary studies we gave rats intravenous (I.V.) nitrite 
(0.5 mL of 300 µM) and measured the gastric nitrite levels over 30 minutes. As shown in 
Figure 33, when the stomach was filled with saline (pH 5.6) or bicarbonate (pH 8.4), it 
appears that the stomach nitrite concentrations rose as the plasma levels fell. However, 
when the stomach pH was low (pH 2.0), gastric nitrite levels remained below the level of 
detection for the entire 30 minutes. Interestingly, the nitrite concentration in the bile 
significantly increases after a gastric or IV bolus of nitrite, suggesting the liver may play 
an important role in regulating circulating nitrite levels. These preliminary experiments 
provide a starting point for future work that will hopefully shed more light into the 
stomach processing of nitrite when the gastric pH is altered, as it is in newborn infants. 
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Figure 33. Nitrite concentrations in gastric fluid and plasma after 0.5 mL of 300 µM 
nitrite was administered IV.  
 
 The exciting and intriguing finding that the gastric contents of newborn infants 
contain high levels of nitrite deserves to be explored further. As a first step, we have 
ruled out a few hypotheses. It seems unlikely that nitrate reducing bacteria, acid 
breakdown of breast milk proteins, or simple concentration of nitrite due to water loss 
from the stomach, are responsible for high stomach nitrite. However, very preliminary 
work in rats suggest that nitrite may be actively pumped from the plasma into the 
stomach where, at a high pH, it can accumulate and lead to higher concentrations than 
can be explained by dietary intake. I urge the future generations of students in our lab and 
elsewhere to continue to explore this and other potential mechanisms.  
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